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ABSTRACT

CHARACTERIZATION OF B CELL DEVELOPMENT AND ACTIVATION IN THE
ABSENCE OF AKT OR PRESENILIN
Marco Calamito
David M. Allman, Ph.D.
The biochemical pathways critical to B cell development remain poorly defined.
Here I characterize a critical role for two separate families of proteins, Akt and
Presenilin in the development and activation of B cells. The absence of Akt1 and
Akt2 leads to a block in marginal zone (MZ) and B1B cell development, as well
as decreased cellularity of splenic follicular B cells.

In addition, I find the

combined loss of Akt1 and Akt2 causes altered B cell receptor repertoire and
poor competitive ability when matched against wild-type B cells.

Similar to

deficiencies in the Akt pathway the combined loss of Presenilin1 and Presenilin2
results in defective MZ, B1B cell development, and altered BCR repertoire
selection. Furthermore, I find that these defects are independent of the Notch
pathway and that Presenilins are required for optimal responses to cross-linking
of the BCR. Collectively, these findings identify and phenotypically characterize
two novel pathways important to B cell development and function.
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Chapter 1:

1.1

INTRODUCTION

Overview

A diverse array of microorganisms present a constant threat to the survival of
higher order animals. The short reproductive cycle of microorganisms endows
these potential pathogens with the ability to rapidly mutate and evolve
mechanisms to evade host clearance.

Mammalian evolution’s answer to the

threat posed by bacteria, virus, fungi, and parasites is a complex and multifaceted immune system.

Both innate and adaptive mechanisms combine to

ensure host survival and reproduction.
As part of adaptive immunity, the humoral immune response is mediated
by antibody producing B cells, capable of recognizing an infinite number of
foreign antigens and providing both short and long term protection to pathogenic
challenge. A growing body of literature suggests that there is a division of labor
within the B cell lineage such that specific subpopulations distinguished by
surface marker expression, activation state and physiological function are
required to combat particular subsets of pathogens at different time points during
the course of infection (Martin, Oliver et al. 2001; Lopes-Carvalho, Foote et al.
2005; Baumgarth, Choi et al. 2008). These B cell populations can be divided in
two distinct groups B1 and B2, with the B2 subset further divided into follicular
(FOL) and marginal zone (MZ) B cells. FOL B cells make up the overwhelming
majority of B-lymphocytes in the mouse, and cooperate with T-cells to form
germinal centers eliciting highly specific responses to protein antigens. While
1

this function may be critical to the survival of the host, primary FOL B cell
responses take on the order of five to seven days to become firmly established
(Jacob, Kassir et al. 1991). It is the responsibility of the innate immune system to
protect the host during this lag phase of the humoral response. MZ and B1 B
cells generate their B cell receptors (BCR) through recombination of
immunoglobulin (Ig) genes and are firmly established in the adaptive arm of the
immune system, yet examination of their function and role in the immune
response demonstrates an “innate-like” quality. MZ and B1 B cells generate
short lived plasma cells with much faster kinetics than do FOL B cells (Martin,
Oliver et al. 2001). Furthermore, the nature of the antigen that MZ and B1 B cells
respond to is often a non-protein, such as conserved glycolipids or carbohydrate
motifs found on the majority of pathogenic organisms (Kearney 2005).

It is

thought, that the ability of these innate-like B cells to recognize and secrete large
quantities of antibody towards these common microorganism components
“bridges the gap” between the early innate immune response and late adaptive
immune response (Martin and Kearney 2002).
Although MZ and B1 B cells exhibit innate like functions and make up only
a small percentage of the total B cell pool, their development requires a complex
array of molecules and signaling pathways activated by the BCR.

A central

feature of B cell development is the requirement to purge the BCR repertoire of
auto-reactive clones (negative selection).

In addition to negative selection,

developing B cells must generate clones with sufficient BCR signaling capacity to
ensure survival i.e. positive selection/tonic signaling. Of particular importance to
2

this complex and poorly defined process, is the lipid kinase phosphoinositide 3kinase (PI-3K). Indeed, mice deficient in the catalytic subunit of PI-3K, p110δ,
fail to develop MZ or B1 B cells while maintaining a FOL B cell pool albeit with
decreased numbers (Clayton, Bardi et al. 2002).

PI-3K signaling is a

downstream target of multiple receptors including antigen, cytokine, and
chemokine receptors, including B cell activating factor (BR3), and Notch
receptors. (Okkenhaug, Ali et al. 2007; Cardoso, Girio et al. 2008; Woodland,
Fox et al. 2008). Recent work has shown that active PI-3K is sufficient to rescue
B cells development and maintenance in the absence of a surface BCR
(Srinivasan, Sasaki et al. 2009). A critical downstream effector of PI-3K is the
serine/threonine kinase Akt. While recent studies have elucidated a function for
Akt in T cell development (Juntilla, Wofford et al. 2007; Mao, Tili et al. 2007) the
role of Akt signaling in the development and activation of B cells remains
undefined.
The data and analysis in Chapter 3 characterizes B cell development in
the combined absence of Akt1 and Akt2, revealing defective peripheral B cell
development, including dramatic decreases in MZ and B1 B cell compartments,
reminiscent of the phenotype observed in PI-3K deficient models (Fruman 2004).
These observations suggest that Akt is a major and required target of PI-3K
signaling in B cell biology. In addition, I demonstrate that Akt1/2 deficient FOL B
cells are poor competitors when mixed with wild-type cells in-vivo and exhibit
defective proliferation to various stimuli in-vitro. Furthermore, the defective MZ B
cell compartment observed in the absence of Akt1/2 is not rescued by enforced
3

expression of the pro-survival molecule B-cell lymphoma-extra large (Bcl-xL).
Finally, I examine the potential connection between Notch and Akt in MZ B cell
development.
In Chapter 4, I expand upon earlier work performed in this lab
demonstrating crosstalk between the BCR and Notch and ultimately uncover a
Notch independent function for the γ-secretase complex and it’s catalytic subunits
Presenilin 1 (PS1) and Presenilin 2 (PS2) in B cell development and activation.
In sum, my work contributes to our understanding of the factors controlling B cell
biology by further defining the molecules critical to B cell development, activation,
and BCR repertoire formation.

1.2

Mature peripheral B cell subsets: phenotype and function

Naive mature B lymphocytes are classically divided based upon surface marker
expression and function into one of three distinct populations; follicular (FOL),
marginal zone (MZ) and B1 B cells (Fig 1). Together these subsets form the
cellular foundation of the humoral immune response, allowing protection to a
wide array of antigens.

1.2.1 Follicular B cells
The adult mouse spleen contains roughly 30 million B cells, the majority of which
are small long lived (~4.5months) re-circulating FOL B cells (Lopes-Carvalho and
Kearney 2004). FOL B cells reside in the follicle of the lymph node and spleen,
adjacent to T cell zones enabling these two populations to interact at the
4

interface betIen the two areas during a thymus dependent (TD) response (Pillai
and Cariappa 2009). Antigen receptor stimulation of FOL B cells in conjunction
with T cell help leads to proliferation, plasmablast formation and the eventual
formation of a germinal center where somatic hypermutation and isotype
switching occur. (Benson, Erickson et al. 2007). These processes result in the
generation of affinity matured long lived plasma and memory cells conferring
immunity to future exposure with that antigen.

1.2.2 Marginal Zone B cells
In contrast to FOL cells MZ B cells inhabit a distinct anatomical niche located
between the red and white pulp of the spleen. It is here that arterial blood
empties into the marginal sinus and is filtered by resident cells including
macrophages, dendritic and MZ B-cells.

Thus, MZ B cells are uniquely

positioned to contact blood borne pathogens (Lopes-Carvalho and Kearney
2004). Indeed, mice lacking MZ B-cells succumb to streptococcus pneumoniae
within days of infection (Tanigaki, Han et al. 2002). Interestingly, MZ B-cells
express higher basal levels of the activation markers CD80, CD86, and MHC
class II. In addition, MZ B-cells are more effective antigen presenting cells than
FOL B-cells, inducing robust T-cell responses (Attanavanich and Kearney 2004).
MZ-B cells were long thought to be sessile, and while it remains true that these
cells do not exit the spleen, recent evidence shows that MZ B-cells are highly
motile, migrating every few hours from the marginal sinus area to the B-cell
follicle (Cinamon, Matloubian et al. 2004; Cinamon, Zachariah et al. 2008).
5

Despite representing only five percent of the splenic B cell pool, MZ cells along
with B1 cells dominate early humoral immune responses to T-independent
antigens (Martin, Oliver et al. 2001).

In addition, MZ B-cells are hyper-

responsive to toll-like receptor (TLR) stimuli, and upon activation quickly
differentiate into IgM secreting plasma cells (Oliver, Martin et al. 1997).
(Functional differences summarized in Table 1). These observations have lead
to a model in which MZ and B1 B cells function to bridge the gap from the early
humoral response to the late affinity matured FOL B-cell dominated response.
Finally, FOL and MZ B-cells differentially express surface IgM, the complement
receptor CD21/35, and low affinity IgE receptor CD23, enabling identification
through flow cytometric based strategies summarized in Table 2.

1.2.3 B1 B cells
B1 B cells are highly enriched in peritoneal and pleural cavities, contribute to Tindependent responses, and can be subdivided based on expression of the
surface marker CD5 into CD5+ B1a and CD5- B1b B cells.

B1a B cells

spontaneously secrete IgM providing a first line defense against encapsulated
bacteria, and are thought to provide a more innate like function (Haas, Poe et al.
2005). B1b cells can be rapidly induced to secrete antibody to T-independent
antigens helping to clear pathogen and aid in long term immunity (Alugupalli,
Leong et al. 2004). As mentioned above, B1 and MZ B cells tend to express
BCRs that recognize conserved components found on microorganisms.
Interestingly, many B1 B cells lack N-additions, and thus possess germ-line
6

encoded antigen receptors that afford protection against a wide range of
pathogens (Feeney 1990; Gu, Forster et al. 1990). For example B1 B cells are
enriched for a VHVL pair with specificity for phosphocholine (T15 idiotype), a
common component of bacterial cell walls (Gu, Forster et al. 1990; Feeney
1991).

Adoptive transfer of T15 antibody affords passive immunity to

streptococcus pneumoniae (Briles, Nahm et al. 1981). These observations imply
that germ-line encoded BCRs have an innate-like ability to recognize microbial
products and as such could be selected for during evolution.
In contrast to the accepted role for B1 cells in the early humoral response,
the development of these cells is anything but clear. Two models have been
advanced to explain the ontogeny of the B1 compartment, the lineage model and
the selection model (Dorshkind and Montecino-Rodriguez 2007). The lineage
model is based upon the observation that fetal liver progenitors are best able to
reconstitute the B1 compartment when compared to adult marrow progenitors,
and that B1 cells possess the capacity for self-renew (Kantor, Stall et al. 1992;
Kantor, Stall et al. 1995; Montecino-Rodriguez, Leathers et al. 2006).

The

enhanced ability of fetal progenitors to form B1 B cells is perhaps the result of
ligand/cytokine variations in fetal vs. adult B cell development that influence
expression of genes important to the B1 fate such as terminal deoxynucleotidyl
transferase (TdT).
In contrast, the selection model proposes that both the B1 and B2 lineage
share a common precursor cell, and signals derived from the BCR will direct cell
fate (Pennell, Mercolino et al. 1989; Arnold, Pennell et al. 1994; Lam and
7

Rajewsky 1999). This notion is supported by data demonstrating that B2 cells
can be induced to up-regulate surface expression of the B1 marker CD5 upon
BCR cross-linking (Wortis, Teutsch et al. 1995).

Table 1: Characteristics of naïve mature B cell populations
Functional
FOL
MZ
Characteristics

B1

Spleen
Localization

Peritoneal Cavity
Lymph Node

Spleen
Spleen

Bone Marrow
T Independent
Weak

Strong

Strong

Strong

Weak

Proliferation

Death

Death

Mild

Strong

Strong

Proliferation

Proliferation

Proliferation

Response
T Dependent
Response
BCR Response

TLR-Ligand Response
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Table 2: Surface marker expression of murine B cell subsets
Tissue
Cell Surface Marker
Bone Marrow

CD19

B220

CD43

AA4

IgM

Pro-B

+

+

+

+

-

Pre-B

+

+

+/-

+

-

Immature B

+

+

-

+

+

Mature B

+

+

-

-

+

CD19

CD23

CD21/35

AA4

IgM

Transitional 1

+

-

+/-

+

+++

Transitional 2

+

+

+

+

+++

Transitional 3

+

+

++

+

++

MZP

+

+

+++

+/-

+++

FOL

+

+

++

-

++

MZ

+

-

+++

-

+++

CD19

B220

CD43

CD5

IgM

B1a

+

+/-

+

+

+++

B1b

+

+/-

+

-

+++

Spleen

Peritoneal
Cavity
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Figure 1: Gating scheme for flow cytometric analysis of murine B cell subsets. (A)
Flow cytometric analysis of BM cells from c57/B6 mice aged 12 weeks. The left-most plots
B6+
are gated on viable donor-derived (DAPI Ly5 ) cells. Numbers in plots indicate the
frequency of events in the indicated gate as a function of the indicated parent population.
+
+
+
+
low
+
+
Pro-B, CD43 B220 CD19 AA4 ; pre-B, CD43 B220 IgM AA4 ; immature B, CD43
+
+
+
+
+
+++
+
B220 IgM AA4 ; mature B, CD43 B220 IgM AA4 . (B) Fr.I, IgM CD21/35 , Fr.II
++
++
+++
+++
+
+
+
+
IgM CD21/35 , Fr.III IgM CD21/35 , (T1 CD23 AA4 ) (T2 CD23 AA4 ) (T3 CD23
+
+
+
+/+
AA4 ) (FOL CD23 AA4 ) (MZP CD23 AA4 ) (MZ CD23 AA4 ). (C) B2 CD43 B220 ; B1
+
Int-Low
+
CD43 B220
; within in B1 gate B1a (CD5 ) B1b(CD5 ).
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1.3

B cell development

1.3.1 B cell development in the bone marrow
Peripheral B cell compartments derive from B-lineage committed precursors
resident in the liver during fetal life, and then in the bone marrow of adult mice.
Precursors expressing high levels of the early B cell factor (EBF) restrict lineage
potential and in conjunction with Pax-5 commit progenitors to the B cell fate
(Cobaleda, Schebesta et al. 2007; Pongubala, Northrup et al. 2008).
Early B cell populations in the bone marrow sequentially transit a series of
phenotypically distinct stages consisting of pro, pre, and immature B cell pools.
Each of these populations can be defined by differential expression of surface
markers consisting of CD19, B220, CD43, AA4 and IgM (Hardy, Li et al. 2000),
[see Table 2 and Fig 1 for surface marker classification scheme]. These early
precursors initiate expression of recombinase-activating genes (RAG), undergo
rearrangement of germline encoded diversity (D) and joining (J) Ig heavy chain
genes. Active rearrangement of variable (V) heavy chain genes marks pro-B
cells (Nemazee 2006). In frame recombination of VH with existing DHJH gene
segments will lead to expression of an intact Ig heavy chain, which pairs with a
surrogate light chain (SLC) to form a pre-BCR. The pre-BCR signals through Igα and Ig-β resulting in a rapid decrease in RAG protein levels and cessation of
heavy chain rearrangement (Jung, Giallourakis et al. 2006). Cells at this stage
also grow in size and undergo an intensive proliferative burst. B cells deficient in
the ability to successfully generate or transmit signals through the pre-BCR, as is
the case in RAG, Igα, or Igβ deficient mice are blocked at this early stage of B
11

cell development (Herzog, Reth et al. 2009). These observations underscore the
fundamental importance the Ig heavy chain plays in the survival of the earliest B
cells.
As cells exit cell cycle and conclude the massive wave of proliferation
sparked by pre-BCR signaling, CD43 expression is decreased and the RAG
proteins are re-expressed.

At this stage Ig light chains commence

rearrangement. Two different clusters of Ig genes are capable of generating light
chains, the kappa (κ) and lambda (λ) loci. Light chain rearrangement proceeds
in an ordered fashion with the κ-locus preceding the λ-locus.

Productive

rearrangement and pairing of heavy and light chain leads to surface expression
of a mature BCR in the form of IgM. Surface IgM expression defines entry into
the immature stage of bone marrow B cell development. It is at this stage that
the BCR specificity of each respective B cell clone is first screened for autoreactivity.

Clones with BCRs recognizing multivalent self-antigens undergo

clonal deletion or receptor editing (Nemazee and Burki 1989; Hartley, Crosbie et
al. 1991).

Recent work has demonstrated that, for membrane bound self

antigens, receptor editing is the dominant mechanism by which auto-reactive
specificities are purged from the immunoglobulin repertoire (Halverson, Torres et
al. 2004).

Clones possessing weak reactivity to self or recognizing soluble

antigens are capable of reaching peripheral B cell compartments, but these cells
are nonfunctional (anergic) with high turnover rates if matched against wild-type
competitors (Cyster, Hartley et al. 1994). Consequently, though the adult murine
bone marrow produces roughly 15 million immature B cells per day, only 10% of
12

these cells leave the bone marrow (Allman, Ferguson et al. 1993; Rolink,
Andersson et al. 1998). The short half-life of immature B cells and extended life
span of mature B cell compartments implies tremendous selective pressure is
placed on immature B cells, and show active negative selection in B cell
development. Those rare clones that successfully transit negative selection in
the bone marrow are able to home via the blood to peripheral lymphoid organs
such as the spleen.

1.3.2 Peripheral B cell development in the spleen
Immature B cells in the spleen are termed transitional cells; phenotypically these
cells are subdivided into three distinct subsets based on termed transitional 1
(T1), transitional 2 (T2), and transitional 3 (T3).

These cell types are

differentiated based on differential surface expression of AA4, CD23, IgM and
CD21/35 (see table 2, Fig1/2). The majority of transitional B cell in the spleen of
an adult mouse will give rise to mature FOL B cells, and a minor fraction of
transitional cells will transit through a marginal zone precursor (MZP) stage of
development en route to a mature MZ B cell (Fig 2). Functionally, these cells are
defined by their rapid turnover and apoptotic response to BCR cross-linking.
Transitional B cells respond to TLR agonists and CD40 receptor cross-linking,
demonstrating these cells are capable of proliferating to certain stimuli (Allman,
Ferguson et al. 1992). The BCR mediated cell death that transitional B cells
experience is in part due to defective generation of nuclear factor kappa-lightchain enhancer of activated B cells (NF-κB) targets A1 and Bcl-xL (Castro, Wright
13

et al. 2009). The rapid cell turnover and apoptotic BCR response suggest that
transitional B cell populations are also actively undergoing negative selection,
purging auto-reactive specificities from the developing B cell pool and ensuring a
self tolerant mature B cell compartment. However, there is a growing body of
evidence demonstrating the importance of BCR specificity in positive selection to
the B1, MZ or FOL B cell compartments.
The notion that positive selection exists for B cells, is supported by a
landmark study demonstrating that the BCR is required for the survival and
persistence of mature B cell populations (Lam, Kuhn et al. 1997). This work was
later extended to show a requirement for BCR signaling in of itself for proper B
cell maintenance (Kraus, Alimzhanov et al. 2004). In addition, light chain V gene
segments while diverse in the pre-B and transitional pools, are skewed towards
certain V genes in the mature compartment (Gu, Tarlinton et al. 1991; Levine,
Haberman et al. 2000), implying both positive and negative selective pressure on
certain VH VL pairs.

Furthermore, evidence for B cell positive selection was

substantiated by the observation that B cells specific for the Thy-1 glycoprotein, a
self antigen, can be selected into the B1 compartment in normal mice and into
the MZ B cell pool in mice expressing low levels of Thy-1 (Hayakawa, Asano et
al. 1999; Wen, Brill-Dashoff et al. 2005).

These studies imply that BCR

specificity, and perhaps signal strength play a role in the B1, MZ or FOL cell fate
decision of those cells gaining access to long lived B cell pools.
Casola et al demonstrated that stronger BCR signals lead to the
generation of B1, while weaker BCR signaling was conducive to formation of MZ
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and FOL B cell populations (Casola, Otipoby et al. 2004). In addition, while the
FOL B cell compartment is intact, albeit compromised, in mice deficient in
molecules critical to BCR signaling such as Bruton’s tyrosine kinase (Btk) or
CD19, these cells fail to compete with wild-type B cells in mixed marrow
chimeras (Sprent and Bruce 1984; Otero, Anzelon et al. 2003)

These

observations suggest that the “fitness” of a BCR is sensed through transient
interaction with self ligands and/or tonic BCR signaling, and that this in turn
governs the make up of the B cell pool.
A key receptor that works in concert with the BCR to maintain the
peripheral B cell repertoire is the B cell-activating factor receptor (BR3),
expressed on FOL, MZ, and late transitional cells and it’s ligand B lymphocyte
stimulator (Blys) (Moore, Belvedere et al. 1999; Harless, Lentz et al. 2001). Mice
deficient in BR3 or in Blys have decreased MZ and FOL B cell numbers that can
be partially rescued by enforced expression of the pro-survival molecule Bcl-xL
(Lentz, Cancro et al. 1996; Lentz, Hayes et al. 1998; Batten, Groom et al. 2000;
Harless, Lentz et al. 2001; Amanna, Dingwall et al. 2003). Interestingly, BR3
signaling is not required for the generation or survival of B1 B cells (Lentz, Hayes
et al. 1998). Recent studies by Stadanlick et al. have established a molecular
mechanism of BCR-BR3 cross-talk (Stadanlick, Kaileh et al. 2008). This work
demonstrates that tonic signaling through the BCR generates the classical NFκB
target p100, p100 then serves as a substrate for processing by BR3 leading to
increased expression of pro-survival molecules Bcl-xL and Pim2; thus regulating
peripheral B cell numbers. These observations support the notion that BCRs are
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not only screened for auto reactivity, but also for “fitness” as assayed by the
ability to generate p100.

Figure 2: Peripheral B cell subsets and development. Immature B cells from the
bone marrow enter the spleen (top) via the blood and are termed Transitional (T1 and
T2) T2 B cells mature into either the follicular (FOL) or marginal zone (MZ) fates.
This decision is dictated in part by BCR signal strength. MZ development requires
CD19/PI-3K, Notch2, and Blys whereas normal FOL development requires Blys. B1
B cells home to the peritoneal cavity (bottom) and are most efficiently generated
during fetal life. Some immature B-cells harbor BCRs of sufficient BCR signal
strength to drive the B1 B cell fate. B1s can be further subdivided into the B1a or B1b
lineage.
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1.4

BCR signaling pathways and the importance of PI-3K.
Though a wealth of knowledge regarding the signaling pathways activated

downstream of the BCR exists, questions remain regarding the how these
effectors are utilized in the context of B cell development and peripheral B cell
fate decisions. The BCR signaling complex is composed of membrane bound
IgM associated with the signal transducing Igα-Igβ heterodimer (Tolar, Sohn et
al. 2008).

BCR aggregation leads to the recruitment of numerous kinases,

adaptors, and lipid modifying enzymes that serve to propagate activation signals
to downstream secondary effectors. A key molecule in this signaling cascade is
the lipid modifying enzyme phosphoinositide 3-kinase (PI-3K).

PI-3K

phosphorylates the inositol group of phosphatidylinositol (4,5)-bisphosphate
(PIP2)

to

form

phosphatidylinositol

(3,4,5)-trisphosphate

(PIP3).

BCR

oligermerization leads to rapid PI-3K recruitment via the B cell cytoplasmic
adaptor protein (BCAP). PI-3K proceeds to generate PIP3 which can serve as a
docking site at the plasma membrane for pleckstrin homology (PH) containing
proteins (Fruman 2004). Molecules such as Btk and phospholipase C gamma 2
(PLCγ2) are recruited through their PH domains to the plasma membrane where
they are phosphorylated by spleen tyrosine kinase (Syk) or other receptor
associated tyrosine kinases.

Activated Btk phosphorylates PLCγ2 leading to

increased generation of the secondary messengers inositol triphosphate (IP3)
and diaglycerol (DAG) (Watanabe, Hashimoto et al. 2001). These molecules
then activate calcium mobilization and protein kinase C (PKC) respectively,

17

leading to the activation of NFκB and nuclear factor of activated T cells (NFAT)
transcription factor families (Fig 3) (Scharenberg, Humphries et al. 2007).
There exist three different classes of PI-3K molecules. In cells of the
immune system class I family members are the best characterized. Class I PI-3K
molecules consist of a catalytic subunit that carries out generation of PIP3 from
PIP2, referred to in general terms as p110. Of the three p110 isoforms (p110α,
p110β, p110δ) p110δ is highly expressed and is the best characterized catalytic
subunit in lymphocytes.

Catalytic subunits pair with an adaptor termed p85,

capable of binding to BCAP and localizing PI-3K at the plasma membrane
(Okkenhaug and Vanhaesebroeck 2003).

PI-3K activity is opposed by

phosphatase and tensin homolog deleted on chromosome 10 (PTEN), an
enzyme that converts PIP3 into PIP2 (Suzuki, Kaisho et al. 2003).
Deletion of the p110δ subunit from the B-lineage results in a block in the
generation of MZ and B1 B cells, FOL B cell numbers in the spleen are
decreased, in addition, in-vitro proliferative responses to BCR cross-linking are
diminished (Clayton, Bardi et al. 2002; Okkenhaug, Bilancio et al. 2002). Loss of
p85 results in decreases in cellularity for transitional and mature populations, but
an increase in pro-B cells suggesting a bottleneck in development (Fruman,
Snapper et al. 1999; Suzuki, Terauchi et al. 1999). Interestingly, while Btk is a
target of PI-3K signaling, the phenotype of p85α-Btk double deficient B cells is
more severe than deletion of either p85α or Btk alone, suggesting Btk
independent phenotypes associated with the loss of PI-3K activity. (Donahue,
Hess et al. 2004).
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Co-ligation of the BCR and it’s co-receptor CD19 enhances recruitment of
PI-3K to the plasma membrane and decreases the threshold for BCR activation
by 100 fold (Carter and Fearon 1992). Deletion of CD19 from mice results in an
overlapping phenotype with PI-3K deficient B cells, mainly loss of MZ and B1 B
cells, and an inability to compete with wild-type progenitors in mixed marrow
chimeras (Rickert, Rajewsky et al. 1995; Otero, Anzelon et al. 2003).
Interestingly, mice deficient in PTEN exhibit increased B1 and MZ B cell
numbers, and crossing PTEN deficient mice onto a CD19 deficient background
partially rescues MZ development (Anzelon, Wu et al. 2003).

Furthermore,

immature B cells deficient in PTEN do not undergo apoptosis in response to BCR
cross-linking, and in contrast to wild-type cells proliferate (Browne, Del Nagro et
al. 2009). Recent work by Srivinson et al. demonstrated that expression of an
activated form of PI-3K was sufficient to rescue survival of mature B cells in
which the BCR was conditionally deleted (Srinivasan, Sasaki et al. 2009). These
observations highlight the importance of the PI-3K signaling pathway and its
downstream effectors in BCR signaling and B cell biology. One major target of
PI-3K activation is the Akt pathway, to date the direct role of Akt in B cell
development and activation remains undefined.

1.5 The PI-3K target Akt
Oligimerization of the BCR in-vitro leads to transient activation of the Akt
pathway. Coordinate co-ligation of the BCR and CD19 results in enhanced and
prolonged activation of the Akt pathway (Otero, Omori et al. 2001). Akt, also
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known as protein kinase B (PKB) is expressed in three distinctly coded isoforms,
Akt1, Akt2, Akt3. All three Akt isoforms display similar structure and are
recruited/activated via their PH domain by PI-3K activity (Plas and Thompson
2005; Franke 2008). Akt1 is ubiquitously expressed, Akt2 expression is largely
restricted to the pancreas and liver, and Akt3 expression is limited to the neural
tissue (Juntilla and Koretzky 2008). Deletion of Akt1 causes a dwarf phenotype,
in which mice on average are 20% smaller then wild-type aged matched controls
(Cho, Thorvaldsen et al. 2001). Deficiency in Akt2 leads to Insulin resistance
and a diabetes mellitus-like syndrome (Cho, Mu et al. 2001). Mice deficient in
Akt3 are grossly normal, though brain size is reduced 20% (Easton, Cho et al.
2005). The combined loss of Akt1 and Akt2 results in neonatal lethality (Peng,
Xu et al. 2003). Akt signaling regulates a diverse array of cellular outcomes
including metabolism, proliferation, and survival (Figure 3) (Manning and Cantley
2007). In addition to BCR mediated activation, Akt is downstream of BR3 leading
to enhanced metabolic fitness. (Patke, Mecklenbrauker et al. 2006; Otipoby,
Sasaki et al. 2008). The relative importance of Akt in the metabolic fitness and
survival of B cells downstream of signaling mediated by BR3, remains poorly
defined.
Two recent papers characterized thymocyte development in the absence
of Akt signaling. Collectively this work demonstrated a profound defect at the βselection checkpoint, a stage in which the T cell receptor (TCR) beta chain
undergoes VDJ recombination to generate a pre-TCR and is required for
subsequent proliferation and differentiation of early thymocytes.

Progenitors
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deficient in Akt1 and Akt2 showed an increased propensity for apoptosis after
TCR activation, leading to a paucity of mature peripheral T cells (Juntilla, Wofford
et al. 2007; Mao, Tili et al. 2007).
One potential explanation for the decreased survival of Akt1/2 deficient T
cells is an inability to properly regulate the pro-survival molecules Bcl-xL and A1,
common targets regulated by Akt (Veis, Sentman et al. 1993; Mandal, Borowski
et al. 2005). Another possibility is that the decreased glucose uptake and cell
size observed in Akt1/2 deficient thymocytes results in sub-optimal metabolism.
Given that cells at the β-selection checkpoint are about to undergo intense
proliferation that may require optimal energy levels for cell cycle progression and
maturation of the cell. The role of Akt1/2 in an analogous stage of early B cell
development, the pre-BCR mediated proliferative burst, is unknown.
Another receptor critical to T-cell development and capable of activating
Akt is Notch.

Ciofani et al showed enhanced Akt activation and glucose

metabolism in thymocytes cultured with Notch ligands and a constitutively active
form of Akt could overcome the requirement for Notch during T cell development
(Ciofani and Zuniga-Pflucker 2005).

These data suggest that pre-TCR and

Notch signaling converge on the PI-3K/Akt pathway.

In peripheral B cell

development, signaling from the Notch2 receptor is required for the generation of
MZ B cells (Saito, Chiba et al. 2003).

Furthermore, studies have recently

demonstrated that Notch signaling can synergize with the BCR to enhance Akt
activation (Thomas, Calamito et al. 2007). A potential interplay between the
BCR, Notch and Akt remains unexplored in MZ B cell development.
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1.6 The gamma-secretase substrate Notch
MZ B-cell development possesses a unique requirement for Notch signals
(Saito, Chiba et al. 2003). Notch is expressed in four isoforms (Notch 1-4) with
Notch2 preferentially expressed in mature B cells. Notch signaling is initiated by
binding to one of it’s 5 ligands, Jagged 1/2 or Delta-like 1/3/4, leading to
shedding of the extracellular domain via the activity of ADAM (A Disintegrin and
Metallopeptidase)

metalloproteases.

Shedding

enables

the

remaining

transmembrane stalk to be opened up to intramembrane cleavage by the gamma
secretase (γ-secretase) complex. The cytoplasmic cleavage product, intracellular
Notch (ICN), translocates to the nucleus and binds the transcription factor CSL
(for human, CBF1; Drosophila, Suppressor of Hairless; C. elegans, Lag-1) and
the co-activator mastermind-like protein (MAML). This complex initiates
transcription of Notch target genes, including members of the hairy and enhancer
of split (HES) family (Maillard, Fang et al. 2005). Conditional deletion of Notch2,
CSL, Notch ligand delta-like1 (DL1), or expression of a dominate negative MAML
(DNMAML), which blocks canonical Notch signaling through all four Notch
receptors, causes the specific loss of MZ B-cells (Tanigaki, Han et al. 2002;
Saito, Chiba et al. 2003; Hozumi, Negishi et al. 2004; Maillard, Weng et al. 2004).
Notch signaling may down modulate PTEN expression, and thus enhance PI-3K
activity, via HES1, in T-lymphomas (Palomero, Sulis et al. 2007; Calzavara,
Chiaramonte et al. 2008). Furthermore, in-vitro studies from our lab have shown
that FOL-B cells stimulated through the BCR and co-cultured with OP9 stromal
cells expressing-DL1 (OP9-DL1) have increased levels of activated Akt
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compared to FO-B cells cultures with control OP9-GFP cells (Thomas, Calamito
et al. 2007). These observations coupled with the requirement for PI-3K activity
in MZ B cell generation raise the prospect of an important role for Akt
downstream of Notch in B cell biology. Furthermore, splenic B cells express
mRNA for DL1 (Hozumi, Negishi et al. 2004). The role B cell intrinsic Notch
ligands play in B cell activation remains undefined.

1.7 The γ-secretase complex and Presenilin
Within the immune system γ-secretase is mainly associated with Notch
signaling, as Notch activation requires the γ-secretase-dependent cleavage of
Notch receptors within the plasma membrane (Maillard, He et al. 2003). The γsecretase complex is a membrane-embedded aspartyl protease composed of
four different proteins: Presenilin (PS), Nicastrin, and Anterior Pharynx-Defective1 (Aph-1), and Presenilin Enhancer 2 (PEN2) (Parks and Curtis 2007). The
catalytic activity of γ-secretase is contained in the PS proteins, consisting of two
separately encoded isoforms Presenilin 1 (PS1) and Presenilin 2 (PS2).

PS

proteins undergo endopreoteolysis and the amino and carboxy terminal
fragments function together as a heterodimer in the mature γ-secretase complex.
Nicastrin is responsible for the recognition and binding of substrates and along
with PEN2 and APH1 play a role in the stability of the complex (Li, Wolfe et al.
2009). The complex is thought to contain a protenaceous pore that is protected
from the lipid bilayer and provides the hydrophobic environment required for
catalytic activity. Interestingly, the complex drives cleavage of a large number of
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single-pass transmembrane proteins, over 80 to date, with rather promiscuous
cleavage site specificities and is expressed at the plasma membrane in lipid
rafts, endoplasmic reticulum (ER) and the golgi. (Parks and Curtis 2007; Li,
Wolfe et al. 2009). Furthermore, a large body of work has demonstrated that
Presenilin proteins have both catalytic dependent and independent functions
affecting cell adhesion, protein localization/trafficking, apoptosis, development
and calcium regulation (Selkoe and Wolfe 2007).

Mutations in PS1 and PS2

have been linked to familial Alzheimer’s disease (FAD) (Hass, Sato et al. 2009).
Recent work has demonstrated that deletion of both PS1 and PS2 in developing
thymocytes compromised TCR-mediated positive selection (Laky and Fowlkes
2007), suggesting a role for Presenilin and by extension γ-secretase activity in
antigen receptor activation and lymphocyte selection during development.

A

recent paper by Yagi et al further demonstrated the importance of Presenilin
proteins in B cell development, as PS1 PS2 double deficient cells failed to
generate the MZ B lineage, presumably due to failed Notch2 activation (Yagi,
Giallourakis et al. 2008).

These authors also showed that Syk activation

downstream of the BCR was compromised in the absence of PS1 and PS2.
Given that the catalytic subunit of the γ-secretase complex, Presenilin, can be
isolated from various compartments of the cell, and that the complex can cleave
numerous substrates, the potential exists for both Notch dependent and Notch
independent functions for Presenilin and by extension γ-secretase in B cell
development and activation that to date are ill defined.
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Figure 3: PI-3K mediated signaling cascades. PI-3K is recruited to the plasma
membrane by the activity of the BCR, CD19, Notch and BR3. PI-3K mediated generation of
PIP3 is modulated by the activity of PTEN. PIP3 concentrations influence the activation of Akt
dependent and Akt-independent pathways. Akt dependent effects include increased
metabolism, enhanced survival, positive regulation of cell cycle progression, and downmodulation of Foxo family transcription factors allowing decreased expression of RAG. Akt
independent pathways include activation of Btk and PLCγ2 enabling generation of IP3
2+
leading to mobilization of endoplasmic reticulum Ca stores and transcription factor
activation.
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1.8

Summary Chapter 1
The biochemical pathways critical to B cell development remain poorly

defined. Central to B lineage generation and cell fate decisions is the BCR. The
fact that active PI-3K signaling can substitute for the BCR in the survival of
mature B cells demonstrates it’s essential role in B cell biology. PI-3K’s ability to
activate numerous downstream effectors, including Akt, raises questions about
the Akt dependent functions of PI-3K. I aimed to explore the role of Akt1 and
Akt2 in B cell development and activation. In Chapter 3 I describe an essential
and non-redundant function for signals derived from Akt1 and Akt2 in the
development of MZ and B1 B cells. I also show that Akt signaling is critical to
BCR repertoire formation, as measured by λ-light chain frequencies, and the
competitive fitness of peripheral B cell populations. Furthermore, Akt is required
for normal proliferation to BCR cross-linking. I demonstrate, through use of a
Bcl-xL expressing retrovirus, that poor survival is not the sole reason for the block
in MZ B cell development (Calamito, Juntilla et al. 2009). Finally, constitutively
active Akt signaling, while sufficient to drive developing B cells to the MZ fate, is
insufficient to rescue a Notch loss of function approach.
Data published from our lab demonstrated a synergy between γ-secretase
substrate Notch and the BCR, enabling increased Akt signaling and proliferation
(Thomas, Calamito et al. 2007). In Chapter 4 I further explore this connection as
it relates to BCR activation and find that while Notch enhances BCR mediated
proliferation it is not required. Strikingly, in experiments initially performed with γsecretase inhibitors (GSI) and then with a genetic loss of function approach I
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uncover an unanticipated requirement for the γ-secretase complex (GS) in
optimal BCR activation independent of the Notch pathway. In addition, I show
that conditional deletion of the γ-secretase complex subunit Presenilin from the B
cell lineage results in a profound block in the development of B1 and MZ B cells.
Finally, I observe altered BCR repertoire formation and abnormal calcium
mobilization downstream of the BCR in B cells deficient in Presenilin proteins
(Calamito et al. submitted 2010).
Years of intense study by numerous labs have uncovered a great deal of
information about the factors critical to B cell development and thus the humoral
immune response. My work, contributes to our understanding of these
requirements, defining for the first time the importance of Akt in B cell
development and uncovering an unexpected role for the Presenilin family of
proteins in B cell biology independent of the Notch pathway.
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CHAPTER 2:

Materials and Methods

2.1 Animals
C57BL/6 and CD19-Cre mice were purchased from Jackson Laboratories (Bar
Harbor, ME). B6.Ly5SJL females were obtained from the National Cancer Institute
(Frederick, MD). Mice deficient in Akt1 or Akt2 were provided by Dr. Morris
Birnbaum (University of Pennsylvania), Rosa26-DNMAML and floxed Presenilin
1 Presenilin 2 null mice were provided by Dr. Warren Pear (University of
Pennsylvania) and Dr. BJ Fowlkes (NIH), respectively. Myristoylated-Akt mice
provided by Dr. Hooman Noorchashm (University of Pennsylvania). All animal
procedures were approved by University of Pennsylvania Institutional Animal
Care and Use Committee.

2.2 Chimera Construction
Fetal liver cells from B6.Ly5SJL, or B6-backcrossed (Ly5B6+) embryos lacking one
or two alleles of Akt1 and/or Akt2 were harvested at day 14.5-16.5 postcoitum,
and cultured overnight in αMEM with 20% FBS, 2.2g/liter sodium bicarbonate,
2mM glutamine, penstrep, 10ng/mL IL-6, 20ng/mL IL-3 and 100µg/mL stem cell
factor. Host B6.Ly5SJL female mice were irradiated with two doses of 550 rads at
least four hours apart. Six hours after the second irradiation 2.5 x 105 cells were
injected intravenously. For double chimeras B6.Ly5SJL progenitors were mixed
50:50 with Akt deficient cells before injection into irradiated B6.Ly5SJL females.
Hosts were maintained on water containing a Bactrim suspension (400 mg
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sulfamethoxazole and 80 mg trimethoprim per 500 ml water) for two days prior
to, and at least two weeks following irradiation. Water was changed and a new
dose of Bactrim added every two to three days.

2.3

Flow Cytometry

For flow cytometric analyses RBC-depleted cell suspensions from BM, spleen or
peritoneal cavity were prepared and stained with optimal dilutions of directly
conjugated antibodies in FACS buffer (1xPBS, 5% BSA, 1mM EDTA) before
analysis a 14-color LSR II flow cytometer (BectonDickinson, San Jose, CA)
equipped with four lasers for excitation of UV, violet, blue, and red-excited dyes.
1-2 x 106 cells were stained with optimal dilutions of antibodies in a 96-well round
bottom plates in a final volume of 50µL. Antibodies used included fluorescein
(FL), phycoerythrin (PE), PE-Cy5.5, PE-Cy7, allophycocyanin (APC), APCCy5.5, APC-Alexa750 or biotin (BI)-conjugated versions of monoclonal
antibodies to the following cell surface antigens: Gr-1 (8C5), F4/80 (BM8) Ter119, CD3 (2C11), CD127/IL-7Ra (A7R34), CD135/Flt3 (A2F10), CD117/c-kit
(2B8), Sca-1/Ly6 A/E (E13-161.7) B220 (RA3-6B2), CD43 (S7), CD23 (B3B4),
IgM (331), κ (187.1), λ1-3 (R26-46), λ1-2 (JC5-1), CD21/35 (7G6), Ly5B6 (104),
Ly5SJL (A20), CD11b (M1/70), C1qR/AA4 (AA4.1), CD5 (53-7.3) and CD19 (6D5).
Polyclonal

FL-conjugated

Fab

goat-anti-IgM

antibodies

(Jackson

ImmunoResearch) were also employed. BI-conjugated antibodies were revealed
with streptavidin (SA) coupled to PE-TexasRed (Caltag, Burlingame, CA). All
directly conjugated antibodies were purchased from eBiosciences (San Diego,
29

CA) except for APC-Cy5.5 CD19 (Caltag), PE κ (BD Bioscience) Fitc λ1-3 (R2646) (BD Bioscience), PE λ1-2 (JC5-1) (Southern Biotech), and PE-Cy5.5
CD21/35 which was purified and conjugated by standard methods in our
laboratory. Non-viable cells were excluded from all analyses by staining with the
UV-excited DNA dye DAPI. All flow cytometric data were analyzed by uploading
files into FlowJo 8.8 (Tree Star, Inc., San Carlos, CA). Cell sorting was performed
on a FACS Aria three lasers for excitation of violet, blue, and red-excited dyes.

2.4

Magnetic activated cell sorting enrichment of splenocytes

Follicular splenic B cells were isolated by first mechanical dissociation between
two frosted glass slides. The resulting mixture was then passed through 80µM
filter (Fisher Scientific). Red blood cell lysis with ACK (NH4Cl, KHCO3, Na2EDTA) for 5 minutes on ice and washed in FACS buffer (1xPBS, 5% BSA, 1mM
EDTA).

Cells were spun down and the supernatant decanted.

Cells re-

suspendend in 2mL of FACS buffer per spleen and 5ul of anti-CD23 biotin (lab
made) added for 15 minutes at 4°C. Cells then washed in 13mL of FACS buffer,
spun down and the supernatant decanted and re-suspended in 1mL per spleen
of FACS buffer. 80µL/mL of streptavidin microbeads was added and enrichment
of FOL B cells a positive selection using BI-CD23 antibodies and SA microbeads
with (MACS) LS columns (Miltenyi Biotec Auburn, Ca) according to the
manufacturer’s instructions resulting in purity greater than 95%.
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2.5

In-vitro B cell cultures
To assess cell division, splenic B cells isolated as above, were labeled

with 5µM CFSE (Invitrogen, Carlsbad, CA) for 2 minutes in PBS. Subsequently 2
x104 CD23+ cells per well were cultured in a 96 Ill plate in RPMI 1640 with 10%
FBS, 2mM L-glutamine, 0.1mM nonessential amino acids, 1xOPI, 55µM b-ME,
and 10mM HEPES. Cells were stimulated with F(ab’)2 goat anti-mouse IgM
(Jackson ImmunoResearch), LPS (Sigma), CpG (IDT). Cultures in which γsecretase inhibitors (GSI, compound E, Calbiochem) were used, GSI was at
100nM.

For [3H]-thymidine experiments, 2x104 sorted B cells per well were

cultured in triplicate per condition for 3 days before being pulsed with 1µCi
(0.037MBq) before harvesting. Cells were collected onto Filtermat (PerkinElmer
Life Sciences) and analyzed on a MicroBeta Trulux scintillation counter
(PerkinElmer Life science). For mixing experiments, 2x104 total cells per Ill (3:1
ratio PS1/2 DKO: WTSJL) were cultured for three days and harvested. For
staining cells were first incubated on ice for 15min with FcR Block (2.4G2), and
then stained with Ly5B6 (104) and Ly5SJL (A20) and CFSE dilution assessed on a
FACS Canto.

2.6 Quantitative real-time PCR
Cells from at least three C57BL/6 mice were pooled and 1x105 cells from each
respective population sorted on a FACS Aria. Tissue samples from liver and
brain were not sorted but isolated in bulk. Qiagen (Valencia, CA) RNeasy Mini
Kits were used to isolate RNA as per instructions provided with the kit, and RNA
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was reverse transcribed using first strand cDNA synthesis kit, protocol provided
in kit (GE Healthcare). Quantitative RT-PCR (qRT-PCR) was performed using
pre-validated Taqman primer/probes set for Akt1, Akt2, and Akt3 with 18s used
as an endogenous control (Applied Biosystems, Fostre City, CA). Data were
normalized to respective Akt isoform expression in follicular B cells. In addition,
delta-CT values were calculated by subtracting the average Ct for the 18s
primer/probe for each population from the respective Akt isoform. For Akt1-/- Akt2/-

B cell populations were sorted as above and Akt3 transcript levels compared to

the corresponding population from wild type mice.

2.7

Retroviral supernatant

293T cells were co-transfected with either MigR1-GFP, MigR1-Bcl-xL-GFP, or
MigR1-DNMAML-GFP and helper plasmid as per protocols outlined in (Pear
2001). Fuguene (Roche) mediated transfection was performed with 8-12µg
MigR1 constructs and 4-6µg helper plasmid. Cell culture supernatants harvested
24 and 48 hours post transfection and stored at -80°C.
2.8

Retroviral transduction

Bcl-xL
MigR1-GFP or MigR Bcl-xL GFP constructs were transduced by retro-virus into
AKT DKO day 15 fetal liver cells. Fetal liver cells were harvested as above and
placed into aMEM media supplemented with 10% FCS, 2mM glutamine, 1%
penstrep, 10ng/mL IL-6, 20ng/ml IL-3, and 100µg/mL stem cell factor. 1 day after
harvest cells were subject to spinfection with respective virus + 10µg/mL
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polybrene for 90 min (2500PRM) at 25°C, then placed at 37°C overnight.
Spinfection was repeated the next day, and cells rested for an additional 6 hrs.
Cells were washed 3x in 1xPBS in a total volume of 50mL each wash, and
2.5x105 cells injected into irradiated B6SJL hosts as above.
DNMAML
MigR1-GFP or MigR-DNMAML GFP constructs were transduced into Class II
controlled Myr-Akt bone marrow similar to above, B220, CD3, Gr-1 depleted
adult bone marrow used in place of fetal liver.

2.9

Tat-Cre Incubation

For induction of Rosa26

+/DNMAML-GFP

cells, splenic CD23+ B cells were isolated as

above and washed in HyClone Serum Free media three times and re-suspended
at a final concentration of 5x106/mL with 50µg/mL Tat-Cre for 45min at 37°C.
Pulse was stopped by addition 10x volume of Hyclone media with 10% FBS.
Cells washed twice and rested for 16hrs before sorting live B cells (B220+ Dapi-)
on FACS Aria.

2.10 Calcium Mobilization
10x106 /mL splenic B cells isolated by positive selection as described above in
RPMI 1640 with 10% FBS and loaded with Indo-1AM (invitrogen) 7µg/mL for
45min at 37°C, mixing every 15min. Cells were washed twice in media and run
on an LSR II flow cytometer (Beckton Dickinson).

Indo-1 fluorescence was

analyzed using a 450-DC-LP dichroic beam splitter and emission filters at 530/30
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and 405/20 for free and bound probes respectively. Each sample was run for
60s to collect baseline, then 15µg/mL F(ab’)2 goat anti-mouse IgM (Jackson
ImmunoResearch) was added and collected for an additional 150s at which time
the tube was removed and 1µg/mL ionomycin (Sigma) was added and the
sample collected for an additional 60s.

Thapsigargin 1µM (Fisher Scientific)

treated samples were collected similar to above. Measurement of anti-IgM or
thapsigargin mediated intracellular Ca2+ store release was performed by adding
12.5 mM EGTA (Fisher Scientific).

All samples collected in linear mode on

FACSDiva (Beckton Dickinson) software and analyzed in FlowJo 8.8 (Tree Star,
Inc., San Carlos, CA ) using kinetic analysis.

2.11

Statistical Analysis

All cell percentages and cell numbers were evaluated with unpaired two-tailed ttest using Excel software. Absolute cell numbers were calculated by multiplying
the frequency of cells within each B cell subset by the total cells harvested from
each respective organ.
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CHAPTER 3 Akt signaling promotes peripheral B cell development and
competitive fitness
3.1

Introduction: Importance of Akt signaling in B cell development
The serine/threonine kinase Akt consists of three individually encoded

family members termed Akt1, Akt2, or Akt3 (Easton, Cho et al. 2005; Plas and
Thompson 2005).

All three isoforms are similar in structure but vary in

expression pattern across different tissues (Manning and Cantley 2007).
Regardless of cell type or tissue context, Akt signaling is an important mediator
of survival, metabolism, and cell cycle progression (Yang, Tschopp et al. 2004).
Akt lies downstream of phosphatylinositol-3 kinase (PI-3K), a critical target of
antigen receptor signaling in both B cells and T cells; in addition to Akt, PI-3K
also activates other downstream effectors pathways including Tec family kinases
and PLCγ (Okkenhaug and Vanhaesebroeck 2003; Fruman 2004).
In B cells, PI-3K is recruited to the plasma membrane upon cross-linking
of surface BCR molecules, and recruitment of PI-3K is enhanced by the B cell
specific co-receptor CD19 (Del Nagro, Otero et al. 2005).

Antigen receptor

mediated stimulation of PI-3K leads to a transient activation of Akt in B cells, coligation of the BCR and CD19 results in the sustained activation of Akt (Otero,
Omori et al. 2001). In B cells, both PI-3K and CD19 are dispensable for early B
cell development in the bone marrow but are required for the normal generation
of peripheral B cells, such as the B1 and MZ B cell compartments (Otero,
Anzelon et al. 2003; Otero and Rickert 2003). The role of Akt, downstream of PI3K in B cell development remains unclear.
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In this chapter I present results that demonstrate a critical and nonredundant role for Akt1 and Akt2 in the development of the peripheral B cell pool.
To elucidate these findings I generated chimeras established with Akt1 and Akt2
deficient fetal liver and found that B1a and MZ B cell development was
profoundly blocked in Akt1/2 deficient chimeras. In contrast to peripheral B cell
development, immature B cells in the bone marrow were only mildly perturbed. In
addition, Akt1/2 deficient progenitors are poor competitors starting at the late
transitional stage of peripheral B cell development. The BCR repertoire is altered
and proliferative responses to BCR cross-linking are dampened in Akt1/2
deficient FOL B cells. Examination of Akt mRNA expression across multiple
subsets of B cells by qRT-PCR revealed that Akt3 expression is reduced in MZ
and B1 subsets relative to FOL B cells. Interestingly, though Akt3 expression
decreases in the B cell subsets most affected by the loss of Akt1 and Akt2 I
observed that the overall level of Akt3 mRNA was significantly increased
compared to Akt2 (Calamito, Juntilla et al. 2009).
Given the role of Akt in cell survival, I examined the effect of ectopic
expression of the pro-survival gene Bcl-xL , through retroviral transduction of
Akt1/2 deficient progenitors and found it insufficient to rescue MZ B cell
development. Furthermore, the Akt pathway has previously been implicated as
downstream of the Notch family of receptors in thymocyte development (Ciofani
and Zuniga-Pflucker 2005) and enhanced Akt activation has been reported in B
cells exposed to cross-linking anti-IgM antibody in the presence of Notch ligands
(Thomas, Calamito et al. 2007). In addition, Notch signaling is required for the
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generation of MZ B cells, but dispensable for other B cell lineages (Tanigaki, Han
et al. 2002; Saito, Chiba et al. 2003; Hozumi, Negishi et al. 2004; Maillard, Weng
et al. 2004; Wu, Maillard et al. 2007). To examine the role of Akt downstream of
Notch I introduced a dominant negative mastermind (DNMAML), capable of
blocking all Notch receptor signaling, into bone marrow progenitors from mice
harboring a class II promoter driven transgene harboring a constitutively activate
form of Akt (Kouskoff, Fehling et al. 1993; Tuttle, Gill et al. 2001; Maillard, Weng
et al. 2004) This system demonstrated that while an active Akt drives B cells
toward the MZ B cell fate, the presence of this transgene is not sufficient to
rescue a Notch loss of function.
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3.2

Chapter 3 Results

3.2.1 Early B cell development without Akt1 and Akt2.
Developing B cells undergo intense proliferation at the pro to pre B
transition (Nemazee 2006), given Akt’s documented role in cell cycle progression
and survival I sought to examine the role of Akt in early B cell development.
Bone marrow B cell populations were not affected in the absence of a single
isoform of Akt1 or Akt2 (not shown). To assess the role of Akt1 and Akt2 in B
cell development, I transferred fetal liver cells carrying null mutations for Akt1
and/or Akt2 into lethally irradiated Ly5 congenic hosts, and allowed 12-14 weeks
for full reconstitution (Fig 4). Use of the fetal liver chimeras was required due to
the neonatal lethal phenotype of Akt1-/- Akt2-/- (Akt1/2 DKO) mice (Peng, Xu et al.
2003; Juntilla, Wofford et al. 2007). Although combined expression of Akt1 and
Akt2 is required for thymopoiesis beyond the pre-TCR checkpoint, Akt1/2 DKO
progenitors readily generated pre-BCR-dependent pre-B cells in the bone
marrow as well as downstream immature B cells (Fig. 5A). Indeed, if anything
frequencies of Akt1/2 DKO donor-derived pro- (B220low CD43+ AA4+ CD19+), pre(B220low CD43- AA4+ CD19+ sIgM-) and immature (B220low CD43- AA4+ CD19+
sIgM+) BM B cells were elevated. Numbers of pro-, pre-, and immature B cells
were increased ~3, ~4, and ~2 fold, respectively, compared to chimeras
reconstituted with Akt1+/+ Akt2+/- progenitors (Fig. 5B). In contrast, frequencies
and cell numbers of mature recirculating BM B cells derived from Akt1/2 DKO
progenitors were decreased significantly compared to Akt1+/+ Akt2+/- progenitor
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controls (Fig. 5A/B). I conclude that the combined expression of Akt1 and Akt2
are not required to generate pre-B and immature B cells.

Figure 4. Experimental Set-up of Akt1/2 DKO fetal liver chimera
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Figure 5. Akt-deficient progenitors generate marrow B-lineage precursors. (A)
Representative flow cytometric analysis of BM cells from chimeras established with
+/+
+/-/-/Akt1 Akt2 (top) or Akt1 Akt2 (bottom) progenitors 12-14 weeks previously.
B6+
The left-most plots are gated on viable donor-derived (DAPI Ly5 ) cells. Numbers
in plots indicate the frequency of events in the indicated gate as a function of the
+
+
+
+
low
indicated parent population. Pro-B, CD43 B220 CD19 AA4 ; pre-B, CD43
+
+
+
+
+
+
B220 IgM AA4 ; immature B, CD43 B220 IgM AA4 ; mature B, CD43 B220
+
IgM AA4 . (B) Absolute cell numbers for respective BM populations were calculated
using the gates shown in (A) (see methods). Error bars indicate the SEM for each
group, n=5. Data representative of two separate experiments. **= p<.01
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3.2.2 Akt1-2 deficient precursors fail to generate MZ B cells.
The decreased numbers of Akt1/2 DKO mature B cells in the BM raised
the possibility of a role for Akt in peripheral B cell development. To examine this
issue I assessed splenic B cell compartments in Akt1/2 DKO reconstituted
animals. In chimeras established with Akt1/2 DKO progenitors, the donor-derived
follicular B cell pool was decreased only 2-fold compared to chimeras generated
with Akt1+/+ Akt2+/- progenitors. Furthermore frequencies of AA4+ transitional B
cell subpopulations, defined by differential expression levels for CD23 and IgM
(termed T1, T2, and T3), were largely unaffected. In contrast, the development of
MZ B cells was highly dependent on signaling derived from Akt1 and Akt2, as I
was unable to detect donor-derived CD21high IgMhigh CD23low MZ B cells in
chimeras established with Akt1/2 DKO progenitors (Fig. 6). Numbers of splenic
MZ B cell precursors (MZPs), considered immediate precursors for MZ B cells,
were decreased 3-fold compared to control chimeras (Figure 6B). Analyses of
mice deficient in either Akt1 or Akt2 exhibited a normal MZ B cell population (not
shown), suggesting that Akt1 and Akt2 perform overlapping functions required for
MZ B cell development. Altogether, these data show that MZ B cell development
is critically dependent on the combined expression of Akt1 and Akt2.
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Figure 6. MZ B cell development is highly dependent on Akt1/2. (A) Representative analysis
+/+
+/-/-/of splenocytes from chimeras established with Akt1
Akt2 (top) or Akt1 Akt2 (bottom)
progenitors 12-14 weeks previously. Viable donor-derived cells were gated as in Figure 1.
Numbers in plots show the frequency of events as a function of the indicated parent gate. (B)
Absolute cell numbers for respective splenic B cell subsets Ire calculated using the gates shown in
(A) (see methods). Error bars indicate the SEM for each group, n=5. Data representative of two
separate experiments. *=p,.05
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3.2.3 Defective B1 B cell development in Akt1/2-deficient chimeras.
Mice lacking CD19 or the catalytic subunit of PI-3K, p110δ, fail to generate
MZ and B1 B cells (Clayton, Bardi et al. 2002; Jou, Carpino et al. 2002;
Okkenhaug, Bilancio et al. 2002), given that Akt is a major down stream target of
the PI-3K pathways I hypothesized that B1 B cell development might be
compromised in the absence of optimal Akt expression. Therefore I analyzed
frequencies of donor-derived B1 B cells in the peritoneal cavity. As shown (Fig.
7), whereas animals reconstituted with Akt1+/+ Akt2+/- progenitors generated
abundant numbers of CD19+ CD43+ B1 peritoneal cavity B cells, the donorderived B1 B cell pool was detectable but significantly diminished in chimeras
established with Akt1/2 DKO progenitors. Further, frequencies of CD5+ B1a cells
were severely decreased, whereas CD5- CD43+ B1b cells were reduced only 2fold. I conclude that the generation of B1a B cells is also highly dependent on the
Akt pathway and this interpretation is in agreement with previous observations
demonstrating the importance of the PI-3K signaling pathway in the generation of
both MZ and B1 B cells.

43

Figure 7. Requirement for Akt1/2 for B1 B cell development. (A) Representative analysis
+/+
+/-/of peritoneal cavity lymphocytes from chimeras established with Akt1 Akt2 (top) or Akt1
-/Akt2 (bottom) progenitors 12-14 weeks previously. The left-most plots are gated on viable
B6+
+
donor-derived B cells (DAPI Ly5
CD19 ). Numbers in plots show the frequency of events
as a function of the indicated parent gate. (B) Average frequencies for the indicated subsets
+
+
+
+
Ire calculated using the gates shown in (A). B2, CD19 B220 CD43 ; B1, CD19 B220
+
+
+
+
+
+
+
+
CD43 ; B1a, CD19 B220 CD43 CD5 ; B1b, CD19 B220 CD43 CD5 . Error bars indicate
the SEM for each group, n=5. Data representative of two separate experiments. **=p<.01,
***=p<.005
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3.2.4 Diminished proliferation to BCR aggregation without Akt1/2.
B1a and MZ B cell development both require optimal selection via the
BCR. In addition, past studies suggest that BCR aggregation leads to activation
of Akt (Craxton, Jiang et al. 1999). I therefore assessed BCR-mediated activation
and proliferation in Akt1/2 deficient B cells. I isolated CFSE-labeled CD23+
splenic B cells from Akt1/2 DKO or control reconstituted chimeras and stimulated
them with increasing concentrations of anti-IgM antibodies. After 3 days, Akt1/2
deficient B cells exhibited decreases in the number of cell divisions induced by
IgM aggregation and markedly decreased survival as assessed by uptake of the
DNA dye 7-AAD (Fig. 8A), resulting in significant decreases in numbers of viable
B cells (Fig. 8B). Furthermore, while the number of cell divisions occurring in
response to the TLR-4 agonist lipopolysaccharide (LPS) was largely unchanged
between Akt1/2 DKO and Akt1+/+ Akt2+/- B cells, overall cell recoveries for Akt1/2
DKO follicular B cells were significantly reduced, likely due to increased cell
death (Fig. 8). These data suggest that, optimal BCR-mediated B cell
proliferation requires Akt1 and Akt2.
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Figure 8. Akt1/2-deficient B cells exhibit a defective BCR-mediated proliferative
+
response. (A) CFSE-labeled CD23 follicular B cells were left unstimulated (top plots) or
stimulated with 50mg/ml anti-IgM antibodies (middle) or 1ug/mL of LPS (bottom) for 3 days,
stained with the viability dye 7AAD, and analyzed by flow cytometry. The right-most overlay
histograms were gated on viable (7AAD ) cells using the gates indicated in the corresponding
-/-/+/+
+/plots. Black line, Akt1 Akt2 ; gray filled curves, Akt1 Akt2 . (B) Mean numbers of viable
-/-/+/+
+/Akt1 Akt2 or Akt1 Akt2 B cells recovered from triplicate cultures stimulated with the
indicated concentrations of anti-IgM antibodies or LPS were calculated by flow cytometry
using the 7AAD gates shown in (A). Error bars indicate SEMs from 4 animals per group.
Representative of two separate experiments. ***=p<.005

46

3.2.5 The Akt pathway promotes competitive fitness of mature B cells in
vivo.
Past work illustrates that mature B cells lacking CD19 or the tec tyrosine
kinase Btk are unable to compete against wild-type (WT) B cells in vivo (Sprent
and Bruce 1984; Otero, Anzelon et al. 2003; Lindsley, Thomas et al. 2007). This
feature correlates with the inability of mature B cells from these mutants to
undergo cell division upon BCR aggregation in vitro. Given the suboptimal
survival of Akt1/2 DKO B cells in response to BCR cross-linking, I reasoned that
Akt1/2 DKO B cells might also survive poorly when forced to compete against
WT B cells. To test this possibility, I generated double chimeras in which equal
numbers of C57BL/6 (Ly5B6) backcrossed Akt1/2 DKO or control Akt1+/+ Akt2+/fetal liver progenitors were mixed with wild type progenitors from congenic
B6.Ly5SJL mice before transplantation into irradiated B6.Ly5SJL adults. Four
months later recipients Were assessed for the representation of Akt1+/+ Akt2+/- or
Akt1/2 DKO-derived (both Ly5B6+) versus B6.Ly5SJL-derived (Ly5SJL+) B-lineage
cells including BM pro- and pre-B cells, immature (AA4+ IgM+) B cells in the BM
and spleen, and mature splenic follicular, MZP, and MZ B cells. To control for
engraftment of progenitors from each donor, I also assessed the relative
contribution of C57BL/6 versus B6.Ly5SJL progenitors to LSK (Lineage- c-Kit+
Sca1+) BM progenitor pool, which contains hematopoietic stem cells and early
multipotent progenitors.
In the BM, Akt1/2 deficient cells were highly competitive with WT cells
within both the LSK pool and within all B-lineage precursor populations including
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immature IgM+ B cells, as the degree of chimerism for each of these populations
derived from Akt1/2 DKO progenitors paralleled that observed for Akt1+/+ Akt2+/progenitors (Fig. 9B). In sharp contrast, all mature B cell populations including
follicular and MZP B cells in the spleen and mature BM B cells were dramatically
under represented in Akt1/2 DKO + WT compared to Akt1+/+ Akt2+/- + WT double
chimeras (Fig. 9A and 9B). In addition, whereas Akt1/2 DKO and Akt1+/+ Akt2+/cells were equally competitive within the least mature (T1) splenic transitional
subset, I noted a partial loss of Akt1/2 DKO B cells within the more mature T2
transitional subset. Furthermore, in additional double chimeras, Akt1-/- or Akt2-/mature B cells displayed a substantial albeit incomplete inability to compete
against WT cells (not shown).

Altogether these data suggest that the Akt

pathway initiates cellular processes required for competitive survival as immature
B cells transit from the T2 population into mature B cell pools.
Blys and BR3 are major determinants of peripheral B cell numbers and
recent publications demonstrate that Akt is downstream of BR3 (Patke,
Mecklenbrauker et al. 2006; Otipoby, Sasaki et al. 2008; Woodland, Fox et al.
2008). This raised the possibility that BR3 signaling is defective in the absence
of Akt1 and Akt2 thus providing a mechanistic explanation for the inability of
Akt1/2 deficient cells to compete with WT cells.

To address this question, I

isolated FOL splenic B cells from control or Akt1/2 DKO chimeras and cultured
them in the presence of absence of Blys for 72 hrs assaying survival and
metabolic fitness. I found that survival as examined by exclusion of the viability
dye 7-AAD, was enhanced after culture with Blys (Fig 10A). Furthermore, Akt1/2
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deficient cells increased their cell size after culture with Blys, suggesting
enhanced metabolic activity (Fig 10B). Therefore Akt1/2 deficient FOL B cells
are responsive to Blys in terms of survival and metabolism suggesting that BR3Akt1/2 signaling does not regulate FOL B cell survival in-vivo. It is possible that
the concentration of Blys utilized in these experiments (100ng/mL) is in such
excess as to mask any defect downstream of BR3. Alternatively, the absence of
Akt1/2 downstream of BCR signaling could lead to poor generation of the BlysBR3 substrate p100 compromising the ability of Akt1/2 deficient B cells to
respond to Blys.

49

Figure 9. Akt1/2-deficient B cells compete poorly with wild-type B cells. (A) Double
chimeras were analyzed at 16 weeks post transplantation. (A) Representation of the indicated B
SJL+
+/+
+/-/-/cell subset derived from WT (Ly5
) or Akt1
Akt2
(top) or Akt1 Akt2 (bottom)
progenitors. Each subset was gated as shown in Figure 2. (B) The average ratio of cells in the
B6+
SJL+
indicated subpopulation derived from Ly5
and Ly5
progenitors in double chimeras
+/+
+/-/-/established with Akt1 Akt2 (gray columns) or Akt1 Akt2 (white columns) progenitors was
calculated using gates shown in Figures 1 and 2 with 4 or 5 animals per group. Diamond and “X”
+
+
symbols indicate individual mice. LSK, Lineage c-Kit Sca-1 . Representative of two separate
experiments.
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Figure 10: Survival mediated by Blys is Akt1 Akt2 independent. (A)
+
Survival of CD23 splenocytes from control (Grey) or Akt1/2 DKO (black).
Viability assayed by exclusion of 7-AAD after 72hrs in-vitro culture. (B)
Cells assayed as above, cell size of live (7-AAD ) cells.
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3.2.6 Altered BCR repertoire in Akt1/2 deficient B cells
B cells deficient in CD19 or the downstream PI3K have altered λ+ light
chain repertoires (Diamant, Keren et al. 2005; Llorian, Stamataki et al. 2007),
given that our studies to this stage had demonstrated overlapping phenotypes
betIen CD19, PI-3K and Akt I sought to determine if Akt1/2 deficient B cells
demonstrated a similar BCR repertoire phenotype. Consistent with the notion of
Akt being a major downstream target of PI3K, splenic FOL B cells (CD19+ AA4IgMint CD21/35Int) from Akt1/2 deficient chimeras revealed a dramatic increase in
the percentage of λ+ B cells (Fig. 11A and Table 3). The increase in λ+ B cells
was also detected in both the T1 (CD19+ AA4+ CD23-) and T2 (CD19+ AA4+
CD23+) splenic transitional B cell populations. Furthermore, immature B cells in
the bone marrow (B220+ CD43- AA4+ IgM+) also displayed increased frequencies
of λ+ cells, suggesting that Akt1 and Akt2 are required at these early stages of B
cell development to generate and shape the BCR repertoire.
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Figure 11: Altered BCR repertoire in Akt ½ deficient B cells Representative analysis of
+/+
+/-/bone marrow or splenocytes from chimeras established with Akt1 Akt2 (top) or Akt1
-/Akt2 (bottom) progenitors 12-14 weeks previously. Viable donor-derived cells Ire gated as
in Figure 4 and 5. Numbers in plots show the frequency of events as a function of the
+/+
+/indicated parent gate. Number of animals equals two (Akt1 Akt2 ) or four
-/-/(Akt1 Akt2 ).

Table 3 Frequency of λ+ B cells in Akt1/2 deficient B cells
Tissue
Akt1 +/+ Akt2 +/Akt1-/- Akt2-/Bone Marrow
% λ Positive
Immature B
8.28 (.91)
13.5 (1.2)
Spleen
T1
T2
FO

8.0 (1.2)
6.3 (2.4)
4.6 (.59)

12.2 (1.1)
12.6 (2.1)
8.4 (.41)

B cell subsets were defined as illustrated in figure 4 and figure 5
+/+
+/-/Mean percent of viable gated populations of two (Akt1 Akt2 ) or four (Akt1
-/Akt2 ). Numbers in parentheses represent SEM.
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3.2.7 Akt isoform expression across B cell subsets.
Since pre-B cell frequencies were increased and MZ, MZP, and B1 B cell
frequencies decreased upon deletion of Akt1 and Akt2, I next sought to better
define the expression of each Akt isoform throughout the B cell lineage. My initial
analyses sought to address expression of each isoform in each immature and
mature B cell subpopulation. As shown in Fig 12A, Akt1 and Akt3 transcripts
were present at 3-6 fold higher levels for wild type pro- and immature B cells in
the BM relative to follicular B cells in the spleen. Though Akt3 transcripts were
expressed at higher levels in immature relative to follicular B cells, the expression
of Akt3 was still lower than brain, a tissue shown previously to express high
levels of Akt3 (Easton, Cho et al. 2005). Interestingly, Akt1 and Akt3 expression
appeared to be down regulated both as pro-B cells give rise to pre-B cells, upregulated in immature B cells, and again down regulated as immature B cells
give rise to mature B cells. In addition, relative to follicular B cells, transcript
abundance for Akt1 and Akt3 was decreased further in MZ B cells and their
immediate precursors (MZPs) in the spleen, and in both peritoneal cavity B1
subpopulations. These observations contrast with the expression pattern for
Akt2, which did not vary substantially among any of the B-lineage subsets
examined (Fig. 12A) and was expressed at lower overall levels compared to
Akt1 and Akt3.
Given that past studies have shown that Akt3 is expressed in
unfractionated splenic B cells (Juntilla, Wofford et al. 2007), and pre-B cell
development in wild type and Akt1/2 DKO precursors may be highly dependent
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on Akt3, I sought to further quantify overall expression of each Akt isoform in
each B-lineage population relative to 18s RNA. To this end, for each B-lineage
population I divided the mean signal (Ct) for each Akt isoform by the mean Ct for
18s RNA, thus yielding a delta-Ct for each Akt isoform within each population. As
shown in Figure 12B, whereas Akt1 and Akt3 are expressed at similar levels
among BM and peripheral B cell subsets, Akt2 is expressed at substantially lower
levels (resulting in a significantly higher delta-Ct) in every population. In contrast,
samples from mouse liver, a source of abundant Akt2 transcripts (Altomare,
Lyons et al. 1998) demonstrated significantly lower delta-Ct values.
Finally, to address whether Akt3 expression increases in B-lineage cells
such as pre-B cells lacking Akt1 and Akt2, I compared Akt3 transcript abundance
in wild type and Akt1/2 DKO B-lineage cells. As shown in Figure 12C, Akt3
expression was only modestly increased (1.6-fold) in Akt1/2 DKO pre-B cells
compared to their wild type counterparts. Interestingly, whereas Akt3 transcript
expression was unchanged in most other B-lineage cells, Akt3 transcripts were
increased 3-fold in Akt1/2 DKO MZPs compared to wild type MZPs (Fig. 12C).
Thus, while the absence of Akt1 and Akt2 in MZPs appears to result in increased
mRNA levels for Akt3, this increase is insufficient to rescue MZ B cell
development. Altogether, these data show that while Akt3 mRNA is expressed at
substantial levels in developing and mature B cells, Akt3 expression alone is
unable to drive MZ and B1 B cell development and follicular B cell competitive
fitness.
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Figure 12. Expression of Akt isoforms in B-lineage Cells. (A) Relative Akt isoform
expression in sorted BM, splenic and peritoneal B cell populations measured by qRT-PCR.
Data are expressed relative to wild type follicular B cells. Brain and liver cDNA serve as
positive controls for Akt3 and Akt2 mRNA, respectively. Error bars indicate the relative
quantity minimum and relative quantity maximum for each sample. (B) Delta Ct values for
Akt1, Akt2, and Akt3 relative to endogenous control 18s, within each of the indicated B cell
populations as in (A). (C) Akt3 transcript abundance in sorted B cell populations from Akt1/2
DKO chimeras relative to the corresponding wild-type population.
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3.2.8 Ectopic Bcl-xL expression is insufficient to rescue marginal zone B
cell development in the absence of Akt1 and Akt2.
Given that Akt plays a critical role in the regulation of pro-survival
molecules down stream of PI-3K (Franke 2008) and transgenic expression of
Bcl-xL was able to mediate rescue of splenic B cell numbers in PI-3K deficient
mice (Suzuki, Matsuda et al. 2003), I sought to examine the impact of retroviral
mediated over-expression of Bcl-xL in Akt1/2 DKO progenitors.

Ectopic

expression of Bcl-xL was able to rescue a substantial portion of mature
recirculating B cells in the bone marrow demonstrating the potency of the Bcl-xL
retrovirus. I noted a decrease in the percentage of GFP+ pre and immature B
cells to levels more representative of a wild-type bone marrow compartment (Fig
13A,C).

While Bcl-xL did provide limited rescue to bone marrow B cell

populations it was not sufficient to rescue MZ B cells in the spleen (Fig 13B,C).
These data demonstrate that the pro-survival function of Bcl-xL is insufficient to
rescue MZ B cell development the absence of Akt1 and Akt2. Yet in recirculating
B cell populations enhanced survival does provide benefit, highlighting the
context dependent requirements for Akt in B cell development.

While it is

possible that Akt still plays a critical role in the survival of MZ B cells these data
suggest that Akt interacts with other biochemical pathways critical to the
generation of MZ B cells.
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Figure 13: Impact of enforced Bcl-xL expression fails on BM and peripheral B cell
development from Akt1/2-deficient precursors. (A) Flow cytometric analysis of BM cells
-/-/from chimeras established with Akt1 Akt2 progenitors transduced with retrovirus expressing
MigR1-GFP control (Grey) or MigR1-Bcl-xL (Black) 8 weeks previously. The left-most plots are
B6+
gated on viable donor-derived (DAPI Ly5 ) cells. Numbers in plots indicate the frequency of
+
events in the indicated gate as a function of the indicated parent population. Pro-B, CD43
+
+
+
low
+
+
+
+
+
B220 CD19 AA4 ; pre-B, CD43 B220 IgM AA4 ; immature B, CD43 B220 IgM AA4 ;
+
+
mature B, CD43 B220 IgM AA4 . (B) Flow cytometric analysis of spleen cells from chimeras
in (A); MZ B cells Ire gated as in Figure 2. For (A) and (B) numbers in plots indicate the
frequency of events as a function of the indicated parent population. (C) Percent of donor+
derived GFP cells within the pro, pre, immature, mature B cells pool of the BM and within the
MZ precursor (MZP) and MZ B cell gates. Error Bars represent SEM for 2 mice in MigR1-GFP
and 3 mice in MigR1-Bcl-xL.

58

3.2.9

The requirement for Notch in MZ B cell development is Akt

independent.
A factor critical to MZ B cell development is the γ-secretase substrate
Notch (Tanigaki, Han et al. 2002; Saito, Chiba et al. 2003; Hozumi, Negishi et al.
2004; Maillard, Weng et al. 2004; Yagi, Giallourakis et al. 2008).

Recent

experiments in thymocytes and follicular B cells support a role for the activation
of Akt downstream of the Notch pathway (Ciofani and Zuniga-Pflucker 2005;
Thomas, Calamito et al. 2007). Given my observation that Akt1 and Akt2 are
required for the generation of MZ B cells, I next sought to examine a potential
Notch-Akt connection in MZ B cell development. To test this hypothesis I utilized
mice harboring a constitutively active N-terminal myristoylated Akt1 transgene
(herein termed Mry-Akt) controlled by the MHC class II promoter (Kouskoff,
Fehling et al. 1993; Tuttle, Gill et al. 2001). This construct is expressed in a
manner consistent with endogenous MHC class II genes and therefore will be
expressed in mature B cells which maintain MHC class expression basally
(Glimcher and Kara 1992). Notch signaling was inhibited by retroviral expression
of a dominant negative mastermind version of the Notch/CSL co-activator
MAML1 (DNMAML) transduced into Myr-Akt positive or littermate control Myr-Akt
negative bone marrow (Fig 14). The DNMAML construct has previously been
shown to block MZ B cells development and recapitulate Notch loss of function
studies (Maillard, Weng et al. 2004).
Splenic B cells from chimeras established with control MigR1-GFP in MyrAkt positive progenitors demonstrated consistently increased frequencies of MZ
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B cells demonstrating the activity of the Myr-Akt transgene and it’s positive effect
on MZ B cell development (Fig 15A). Despite the ability of Myr-Akt to positively
impact MZ B cell development/ maintenance, expression of DNMAML in Myr-Akt
positive B cells continued to block MZ B cell development. (Fig 15B) This data
suggests, that while Notch can activate Akt in B cells, Akt activation alone is
insufficient to replace Notch signaling.

Figure 14: Experimental Set-up: Ectopic DNMAML expression in Myr-Akt background
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Figure 15: Myristolayted Akt increases MZ B cell frequency but is insufficient to rescue
Notch inhibition. (A) Flow cytometric analysis of splenic cells from chimeras established with
MigR1-GFP trandsduced bone marrow from Myristolyated-Akt (Myr-Akt) negative littermate
control (top) or Myr-Akt positive (bottom) twelve weeks post reconstitution. The left most plots
+
are gated on live (Dapi ) splenocytes. Middle plots gated on CD19 GFP cells, right most plots
+
+
gated on CD19 GFP . Fraction I,II, and III gated as in figure 4. Numbers represent frequencies
of parent gate. (B) Flow cytometric analysis of splenic cells from chimeras established with
dominant-negative mastermind (DNMAML) transduced bone marrow from Myr-Akt negative
littermate control (top) or Myr-Akt positive (bottom) twelve weeks post reconstitution. Gating as
in (A). Representative of two (MigR1-GFP control) or three (DNMAML) mice.
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3.3 Chapter 3 Summary-Brief Discussion
I have characterized B cell development in the absence of Akt1 and Akt2.
I find that signals derived from Akt1 and Akt2 are not required for the pro to pre B
transition, indeed the total cell counts for each of these respective pools is
increased relative to controls. In the periphery, MZ and B1 cell development is
dramatically impaired, and the competitive fitness of FOL B cells is compromised
in the absence of Akt1 and Akt2 (Fig 16). This phenotypic characterization is
reminiscent of the B cell phenotypes observed in PI-3K and CD19 loss of
function animals (Rickert, Rajewsky et al. 1995; Donahue, Hess et al. 2004;
Okkenhaug, Ali et al. 2007) and supports the hypothesis that Akt is a critical
target of the PI-3K pathway in peripheral B cell development. The increased
frequency and number of pro, pre and immature B cells in the bone marrow of
Akt1/2 deficient chimeras could suggest a bottleneck in development by which
the remaining Akt3 is unable to efficiently and effectively signal maturation in the
absence of Akt1 and Akt2. Alternatively, Akt3 may activate distinct downstream
signaling pathways that exert positive effects on early B cell survival and/or
proliferation. Clearly signals from Akt1 and Akt2 at these developmental stages
are not required for development or survival of these cells. This is in contrast to
observations made in thymocyte development, in which a severe arrest occurs at
the DN3 stage in Akt1/2 deficient thymocytes (Juntilla, Wofford et al. 2007).
These differences may reflect Akt3 expression pattern variations as Akt3 is
expressed at detectable levels in early B cells, but down regulated dramatically in
developing thymocytes. In this model, the aggregate Akt signaling required to
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generate T cells is not reached in the absence of Akt1 and Akt2, but is achieved
for early B cells.

Alternatively, the phenotype could reflect the outcome of

specific downstream targets of Akt3 vs Akt1 and/or Akt2 and their ability to
support early B cell generation. Examination of Akt 1-3 triple knockout B cells
will be required to elucidate Akt3’s role in early B cell development. Interestingly,
I find that the BCR repertoire of Akt1/2 deficient B cells is altered with increased
frequencies of λ+ cells, in both mature and immature B cell subsets, these
observations are in agreement with CD19 deficient B cells, which also display
increased frequencies of λ+ cells across immature and mature B cells subsets
(Diamant, Keren et al. 2005).

The increased λ+ frequency could represent

changes in BCR selection as a result of altered BCR complex signaling
outcomes during development in the absence of Akt. A notion supported by our
in-vitro data illustrating defective proliferative responses to BCR cross-linking.
Alternatively, Akt signaling could be important in shutting down Rag transcription
as observed by Amin and colleagues (Amin and Schlissel 2008) as such it is
possible that cells in the pro and immature B cell stages can not properly
regulate Rag, resulting in continued expression and exhaustion of the κ locus
and eventual progression to the λ locus.
In the periphery, B1 and MZ B cells are thought to be a selected pool,
requiring stronger signals through the BCR (Lopes-Carvalho and Kearney 2004),
given the ability of CD19 to increase the sensitivity of the BCR signaling
(Fujimoto, Poe et al. 2002) it is possible that the loss of MZ and B1 B cells in Akt
1/2 DKO chimeras reflects an inability to generate the “proper” strength of signal
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through the BCR-CD19 complex.

I can conclude that the block in MZ

development is not the result of poor survival, as ectopic expression of Bcl-xL
was unable to rescue development of these cells. Interestingly, it was previously
reported that a Bcl-2 transgene could rescue MZ development in CD19 deficient
animals (Otero, Anzelon et al. 2003).

These data suggest that Akt may be

required in both a CD19 dependent and independent manner during the
generation of MZ B cells. Furthermore, Suzuki et al. demonstrated that a Bcl-xL
transgene could rescue B220+ cells in PI-3K deficient splenocytes, however
these workers did not subset B cell populations and thus the MZ B cell
compartment was not examined (Suzuki, Matsuda et al. 2003). It should be
noted that numerous receptors possess the capacity to activate PI-3K and hence
Akt, including but not limited to chemokine, cytokine, toll-like and co-stimulatory
receptors (Fruman, Snapper et al. 1999; Jou, Carpino et al. 2002; Okkenhaug
and Vanhaesebroeck 2003; Donahue, Hess et al. 2004; Fruman 2004). One
such pathway I explored was the Notch pathway, previously shown to activate
Akt in developing thymocytes (Ciofani and Zuniga-Pflucker 2005; Palomero, Sulis
et al. 2007). My results indicate that the presence of a constitutively active form
of Akt selectively expressed in mature B cells failed to rescue MZ development in
the presence of DNMAML, suggesting that any potential Notch-Akt signaling axis
does not require activation of Akt to generate MZ B cells.
This similarity of developmental phenotypes and defective in-vitro
proliferative responses of Akt1/2 deficient and CD19/PI-3K deficient animals
supports the hypothesis that Akt is a critical downstream target of the PI-3K in
64

the context of B cell development and activation. Clearly, additional experiments
addressing the potential of myr-Akt to rescue the CD19 deficient phenotype or
assessment of positive/negative selection of BCRs with heavy chain transgenic
systems will be required to more definitively demonstrate the role of Akt1/2
downstream of the BCR/CD19 in the context of B cell development.

Figure 16: Akt1/2 in B cell development. Akt1 and Akt2 while dispensable for the
generation of early bone marrow B cells is required for normal cell numbers and lambda
frequencies, suggesting altered receptor editing. Akt1/2 signals are required for the
generation of MZ and B1a cells and to a lesser extent B1b and FOL B cell numbers. Akt1/2
are critical in the competitive fitness of FOL B cells, formation of the primary BCR repertoire,
and proper responses to BCR mediated proliferation.

65

Chapter 4. Notch independent γ-secretase functions in B cell development
and activation
4.1

Introduction: Role γ-secretase complex in lymphocytes.
The Notch pathway has a well documented role in the development of MZ

B cells and though dispensable for the development of FOL B cells it does
enhance their activation (Tanigaki, Han et al. 2002; Saito, Chiba et al. 2003;
Hozumi, Negishi et al. 2004; Thomas, Calamito et al. 2007). Notch signaling is
initiated by receptor-ligand binding. This binding enables metalloproteases to
cleave the extracellular domain of the Notch receptor and leads to ectodomain
shedding. Shedding opens the remaining intramembrane region of the Notch
receptor to be cleaved by the γ-secretase complex, freeing the intracellular
domain of Notch to translocate to the nucleus and activate Notch target genes
(Maillard, Fang et al. 2005). While Notch is a critical target of γ-secretase activity
in MZ B cell development, numerous reports demonstrate the importance γsecretase activity on signaling pathways independent of Notch (Citron, VigoPelfrey et al. 1994; Kopan and Ilagan 2004; Parks and Curtis 2007; Hass, Sato et
al. 2009; Li, Wolfe et al. 2009).

Perhaps the best example is the amyloid

precursor protein (APP), which when mutated, promotes the formation of a 42
amino acid γ-secretase cleavage product at the expense of the normal 40 amino
acid product. This larger cleavage product more readily forms plaques and is
associated with early onset Alzheimer’s disease (Citron, Vigo-Pelfrey et al.
1994). The γ-secretase complex is a multi-protein membrane-imbedded aspartyl
protease, consisting of four proteins: Presenilin, Presenilin enhancer (PEN2),
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Nicastrin, and Anterior Pharynx-Defective-1 (Aph-1) (Li, Wolfe et al. 2009). The
catalytic activity of γ-secretase, which is contained in the PS1 and PS2 proteins,
drives the cleavage of a large number of single-pass transmembrane proteins of
which over 80 substrates have been identified (Parks and Curtis 2007; Li, Wolfe
et al. 2009). The large number of γ-secretase targets has caused it to be loosely
referred to as the “proteasome of the membrane” (Kopan and Ilagan 2004). To
add an additional layer of complexity, γ-secretase can be isolated from the
plasma membrane, the endoplasmic reticulum and the golgi, potentially
implicating it’s function in a diverse array of cellular processes.

These

observations raise the possibility that the γ-secretase complex could play both
Notch dependent and Notch independent roles in B cell development and
activation.
Two recent publications have elucidated a role for the catalytic
components (Presenilin 1 and Presenilin 2) of the γ-secretase complex, in the
development of thymocytes and MZ B cells (Laky and Fowlkes 2007; Yagi,
Giallourakis et al. 2008). However, these studies did not differentiate between
Notch dependent and Notch independent functions of Presenilin proteins.
Indeed, their respective observations are in agreement with Notch loss of
function approaches suggesting that the loss of Presenilins and thus γ-secretase
activity alters T and B cell development at the expected stages, yet the
decreased calcium mobilization in splenocytes activated through the BCR in
Presenilin deficient B cells (Yagi, Giallourakis et al. 2008) is not observed in B
cells with a Notch loss of function (Tanigaki, Han et al. 2002). To clarify these
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issues, I examined B cell subset development and BCR and TLR-mediated B cell
activation upon deletion of PS1 and/or PS2 or inhibition of Notch activity in
developing and mature B cells. Our studies suggest that Presenilins promote B
cell activation, B1 B cell development, and establishment of the primary BCR
repertoire without engagement of the Notch pathway.
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4.2

Chapter 4 Results.

4.2.1 Optimal BCR mediated proliferation requires γ-secretase in a Notch
independent manner.
Recent studies from this lab demonstrated a role for γ-secretase activity in
B cell activation through a synergistic effect of the γ-secretase substrate Notch
and BCR (Thomas, Calamito et al. 2007). These experiments utilized a coculture system in which B cells were added to OP9 stromal cells engineered to
express the Notch ligand Delta-like 1 (OP9-DL1). Given that splenic B cells
express mRNA for DL1 (Hozumi, Negishi et al. 2004), one possibility is that BCRinduced B cell proliferation is amplified via interactions between Notch2 and DL1
on neighboring B cells. To address this possibility I first tested addition of γsecretase inhibitor (GSI, compound E) to purified CFSE-labeled B cells
stimulated with anti-IgM antibody or TLR ligand and measured proliferation in
vitro. After 3 days in culture, GSI treated cells demonstrated significantly reduced
proliferation to various concentrations of anti-IgM antibody (Fig. 17A). Notably,
this effect was specific to stimulation through the BCR, as proliferation in
response to LPS and CpG was not significantly altered (Fig. 17B). Importantly,
exposure of CD23+ B cells to GSI was not toxic to B cells when compared to
vehicle controls (Fig. 17C).
Because multiple γ-secretase substrates outside the Notch pathway have
been identified, I next sought to test whether specific inhibition of Notch activity
also diminished BCR-induced proliferation. To this end, I harvested follicular B
cells from mice carrying an inducible (Cre-dependent) allele encoding a dominant
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negative version of the Notch/CSL coactivator MAML1 in the Rosa26 locus. This
dominant negative form of MAML1, termed DNMAML1, recapitulates all known
loss-of-function

mutations

associated

with

the

Notch

pathway

in

the

hematopoietic system, and is expressed as a GFP fusion protein upon Cremediated deletion of a transcriptional stop cassette in the Rosa26 promoter (Tu,
Fang et al. 2005). Nearly half of follicular B cells from Rosa26+/DNMAML1-GFP mice
pulsed with purified Tat-Cre fusion proteins and rested for 16 hours became
GFP+ (Fig.18A). This approach allowed me to examine the impact of DNMAML1
expression in isolated B cells without potential complications arising from
inhibiting Notch activity during B-lineage development and selection in the BM.
Thus, GFP+ and GFP- CD19+ cells from Tat-Cre cultured Rosa26+/DNMAML1-GFP B
cells were stimulated with increasing doses of anti-IgM or the TLR4 agonist LPS
with or without addition of GSI. Three days later cells were pulsed with 3Hthymidine. As shown (Fig. 18B), inhibition of CSL-dependent Notch signals had
no affect on BCR-induced proliferation across increasing doses of anti-IgM
antibody. Significantly however, exposure of both GFP+ and GFP- cells to GSI
resulted in a dramatic drop in

3

H-thymidine incorporation (Fig. 18B, D).

Furthermore, I also observed normal BCR-induced proliferation in follicular B
cells harvested from CD19+/Cre Rosa26+/DNMAML1-GFP mice (not shown). Altogether,
these data further demonstrate that γ-secretase activity is required for optimal B
cell proliferation in response to BCR cross-linking, and indicate that γ-secretase
promotes optimal BCR signaling independently of CSL mediated Notch activity
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Figure 17. γ-Secretase inhibitors diminish BCR-mediated proliferative responses (A)
+
CFSE-labeled CD23 follicular B cells Ire stimulated with increasing concentrations (as
indicated) of anti-IgM antibody (DMSO/black line) or γ-secretase inhibitor (100nM GSI,
dotted line) (B) Cells isolated as in (A) stimulated with LPS (1µg/ml) or CpG (0.1µM)
+
(DMSO/black line) or (GSI, dotted line). (C) CD23 splenic B cells cultured in-vitro for 24hrs
in the indicated doses of GSI and viability assessed.
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Figure 18: GSI diminishes BCR mediated proliferation is Notch independent. (A)
+
+/DNMAML-GFP
CD23 splenic B cells from Rosa26
mice were pulsed with Tat-Cre for 16 hours
+
+
+
3
before sorting DAPI B220 GFP and DAPI B220 GFP cells. (B) [H]-thymidine uptake by
+
–
sorted GFP or GFP cells from (B) after three days stimulation with the indicated doses of
+
anti-IgM antibodies or LPS (1µg/ml). Solid black bar, GFP ; solid white bar, DNMAML-GFP ;
–
3
+
solid grey bar, DNMAML-GFP plus 100nM GSI. (C) [H]-thymidine uptake by sorted GFP
–
or GFP from (B) treated for three days in the presence of 12.5µg/ml anti-IgM. Bars as in
+
(C) except the grey bar with black shading indicates DNMAML-GFP cells cultured with GSI.
Results are representative of 2-3 separate experiments.
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4.2.2 Presenilins promote optimal BCR but not TLR-induced proliferation.
Given that GSI negatively affects anti-IgM but not LPS or CpG-induced B
cell proliferation when added to wild type or Notch-inhibited (DNMAML1-GFP+) B
cells (Fig. 17 and 18), I tested whether B cells lacking the catalytic components
of γ-secretase exhibit suboptimal proliferative responses to BCR cross linking
and whether this effect is unique to the BCR. In this regard, one recent study
from Yagi et al. showed that B cells lacking Presenilin 1 (PS1) and Presenilin 2
(PS2) fail to enter the cell cycle upon either anti-IgM or LPS stimulation (Yagi,
Giallourakis et al. 2008). However I find that GSI fails to impact B cell
proliferation in response to LPS or CpG stimulation (Fig. 17). To address these
issues I first generated C57BL/6-backcrossed CD19+/Cre mice harboring two
floxed PS1 alleles and two null alleles for PS2. For simplicity I will refer to the
resulting CD19+/Cre PS1f/f PS2-/- mice as PS1/2 DKO mice throughout this
dissertation.
To clarify the cell-intrinsic role of Presenilins in BCR and TLR-mediated B
cell proliferation, I mixed CFSE-labeled CD23+ splenic B cells from PS1/2 DKO
(Ly5B6) and wild type B6.Ly5SJL mice at a 3:1 ratio of PS1/2 DKO and wild type
cells, and stimulated these cells with increasing doses of anti-IgM antibodies or
LPS or CpG. After three days of stimulation with multiple doses of anti-IgM
antibodies, wild type (Ly5SJL+) B cells grew to dominate these cultures (Fig. 19A).
Further, examination of CFSE dilution curves for each population revealed that a
substantially smaller number of PS1/2 DKO B cells completed one or more
rounds of cell division compared to wild type cells cultured under identical
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conditions. Indeed, after three days cell recoveries for PS1/2 DKO B cells were
10-fold lower than wild type cells, whether such cells were mixed before
stimulation or cultured separately (Fig 20A,B). Furthermore, addition of GSI to
PS1/2 DKO B cells did not result in additional decreases in anti-IgM induced
proliferation, indicating that GSI specifically inhibits Presenilins activity in this
context (Fig. 20C). However, proliferative responses of PS1/2 DKO B cells upon
LPS or CpG stimulation were unchanged relative to wild type controls (Fig. 19B).
These data show that γ-secretase activity is required for optimal BCR-mediated
but not TLR-mediated B cell activation, and contrast with a recent study
suggesting that Presenilins regulate responsiveness to TLR ligands such as LPS.
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Figure 19: Presenilins promote BCR but not TLR induced proliferation in follicular
B6+
SJL+
+
B cells. (A) Ly5
(PS1/PS2 DKO) and Ly5
(control) CD23 splenic B cells Ire
CFSE labeled, mixed at a 3:1 ratio, and stimulated with the indicated doses of anti-IgM
antibody for three days (top panel). Plots gated on live (DAPI ) cells. Histograms
illustrate CFSE dilution curves for PS1/PS2 DKO (black) versus wild type (grey) cells for
+
the corresponding dose of anti-IgM antibodies. (B) CFSE-labeled CD23 splenic B cells
cultured with LPS (1µg/ml) or CpG (0.1µM) for three days. Plots gated on live (DAPI )
cells, PS1/PS2 DKO (black) versus wild type (grey). Representative of three
experiments.
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Figure 20. Presenilin proteins are required for optimal BCR mediated proliferation. (A)
SJL+
B6+
+/Cre
f/f
-/+
Viable cell recoveries of Ly5
(black) or Ly5 CD19
PS1 PS2 (white) CD23 cells in
+/Cre
+/+
+/+
a mixed in-vitro culture after three days. (B) Viable cell recoveries of CD19
PS1 PS2
+/Cre
f/f
-/(black) or CD19
PS1 PS2 (white) after three day in-vitro culture, representative of four
+
+/Cre
f/f
-/experiments. (C) CFSE-labeled CD23 splenic B cells from CD19
PS1 PS2 mice were
cultured in-vitro for three days in the presence of vehicle control (solid black line) or 100nM
GSI (red line)
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4.2.3 Compromised calcium mobilization in Presenilin deficient B cells.
Increases in intracellular calcium levels enact a diverse range of functions
and occur due to the induced release of calcium from the endoplasmic reticulum
(ER), and the subsequent intake of extracellular calcium through channels in the
plasma membrane in response to depletion of ER calcium stores (Scharenberg,
Humphries et al. 2007; King and Freedman 2009). A wealth of data indicate that
Presenilins regulate the release and utilization of calcium from the endoplasmic
reticulum (ER) in neurons (Cai, Lin et al. 2006; Tu, Nelson et al. 2006; Cheung,
Shineman et al. 2008) and recent data indicate that Presenilin-deficient
thymocytes exhibit compromised calcium mobilization upon aggregation of the T
cell receptor (Laky and Fowlkes 2007). To test whether diminished BCR-induced
B cell activation correlates with suboptimal calcium responsiveness, I isolated
CD23+ splenic B cells from PS1/PS2 DKO mice as Ill as CD19+/Cre and CD19+/Cre
Rosa26+/DNMAML1-GFP controls, labeled these cells with Indo-1AM, and added antiIgM cross linking antibodies.
In media containing free calcium I observed delayed and marginally
decreased calcium mobilization in PS1/PS2 DKO B cells relative to all controls
including GFP+ cells from CD19+/Cre Rosa26+/DNMAML1-GFP mice (Fig. 21A). As
expected, calcium mobilization was not depressed in Notch-inhibited B cells.
Indeed, in many experiments DNMAML1-GFP+ B cells exhibited a slightly
increased calcium response (Fig 21A). To test directly whether Presenilins
regulate calcium release from the ER, I chelated extracellular calcium by adding
EGTA before aggregation of the BCR. As shown (Fig. 21B), PS1/PS2 DKO B
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cells displayed a modest but consistent decrease in ER calcium store release
upon BCR stimulation
With separate samples I also tested whether Presenilins influence the
intake of extracellular calcium by adding thapsigargin, which depletes ER calcium
stores by blocking SERCA pumps in the ER. As shown (Fig. 21C), CD19+/Cre
control and PS1/PS2 DKO B cells exhibited similar levels of calcium uptake after
adding thapsigargin, suggesting that Presenilins do not play a major role in
calcium homeostasis downstream of the ER. Furthermore, initial calcium levels
within the ER of unstimulated cells appeared normal, as baseline calcium levels
were comparable for CD19+/Cre and PS1/PS2 DKO B cells (Fig. 21A, B), and in
mutant and control samples increases in intracellular calcium levels were not
significantly different upon adding thapsigargin in the presence of EGTA (Fig.
21D). These data are consistent with the notion that Presenilins promote the
BCR-mediated release of intracellular calcium stores from the ER.
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2+

FIGURE 21. Presenilins promote optimal BCR-induced ER Ca release. (A) Mean
+
of calcium mobilization measurements in Indo-1AM loaded CD23 splenic B cells
+/Cre
isolated from control (solid black line), PS1/PS2 DKO (solid grey line), and CD19
+/DNMAML-GFP
Rosa26
(dashed grey line) after stimulation with 15µg/ml anti-IgM antibody
in calcium-containing media. (B) Calcium mobilization cells isolated and stimulated as in
(A) in the presence of 12.5 mM EGTA. (C) Calcium mobilization analysis of cells
isolated as in (A) treated with 1µM thapsigargin in calcium-containing media. (D)
Analysis of calcium mobilization in cells isolated as in (A) and stimulated with 1µM
thapsigargin in the presence of 12.5 mM EGTA.
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4.2.4 Presenilins are critically required for the development of B1 B cells.
Previous reports suggest that enhanced BCR signaling drives the
formation of B1 B cells (Lam and Rajewsky 1999; Casola, Otipoby et al. 2004).
Given that PS DKO B cells exhibited suboptimal responsiveness to BCR
aggregation, I assessed frequencies of all peripheral B cell subsets including B1
B cells in the peritoneal cavity of mice lacking PS1 and PS2 or either PS1 or PS2
alone. Consistent with the expected loss of Notch2 function, the splenic MZ B cell
pool was markedly decreased in PS1/PS2 DKO mice (Fig 22A). In addition,
frequencies of immature transitional and mature follicular B cells in the spleen
and B-lineage progenitors in the BM were unaffected, although I consistently
noted a decline in surface CD21 levels in PS1/PS2 DKO B cells as reported to
occur in Notch-deficient B cells (Saito, Chiba et al. 2003), and I also noted an
unexplained decline in surface CD23 levels as recently noted upon enforced
survival of mature B cells lacking a BCR (Figure 22B) (Srinivasan, Sasaki et al.
2009).
In the peritoneal cavity PS1 and PS2-deficient mice as well as PS1/PS2
DKO mice exhibited a significant decline in frequencies of all CD19+ B220low
CD43+ B1 B cells (Fig. 23A). Furthermore, whereas both B1a (CD5+) and B1b
(CD5-) cells, the two chief subsets of B1 B cells (Dorshkind and MontecinoRodriguez 2007), were equally compromised in PS1- and PS2-deficient mice,
frequencies of B1a cells were especially depressed in PS1/PS2 DKO mice (Fig.
23A). Notably and consistent with past studies, Notch inhibition did not affect the
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size of the B1 pool (Fig. 23B). I conclude that Presenilins promote B1 B cell
development independently of the Notch pathway.
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Figure 22. Impact of loss of Presenilins on splenic B cell subset composition. (A)
+/Cre
+/+
+/+
+/Cre
f/f
+/+
Splenic B cells from CD19
PS1 PS2 (far left), CD19
PS1 PS2 (second from
+/+
+/+
-/+/Cre
f/f
-/left), CD19 PS1 PS2 (third from left), or CD19
PS1 PS2 (far right) were stained
with the indicated antibodies before analysis of 250,000 events on an LSR2 flow cytometer.
int
+
(B) Overlay histograms for the indicated surface proteins. Cells were gated on IgM CD21
+/Cre
+/flox
+/+/Cre
flox/flox
follicular B cells as shown in (A). Black CD19
PS1
PS2 , Red CD19
PS1
+/+
+/+
+/+
-/+/Cre
flox/flox
-/PS2 , Blue CD19
PS1
PS2 , Purple CD19
PS1
PS2 . Data are
representative of at least three animals per group and two separate experiments.
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Figure 23. Defective B1 B cell development without Presenilins. (A) Peritoneal cavity
lymphocytes from the indicated mice were stained with the indicated antibodies before collection
of 100,000 events on an LSR2 flow cytometer. The left-most plots are gated on viable B cells
+
(DAPI CD19 ). Numbers in plots show the frequency of events as a function of the indicated
parent gate. Representative of at least three animals per group and two separate experiments.
(B) Peritoneal cavity lymphocytes from the indicated additional 12-week old mice were stained
+
+/Cre
+/DNMAML-GFP
and analyzed as in (A). All panels gated on DAPI CD19 cells, CD19
Rosa26
+
mice were also gated on GFP cells. Representative of three separate experiments.
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4.2.5 The absence of Presenilin proteins leads to decreased λ+ B cells.
Defects

in

B1

development,

compromised

anti-IgM

proliferative

responses, and altered Ca+ collectively suggest that Presenilins potentiate
optimal BCR signaling. Hence, given that tonic BCR signaling plays a
fundamental role in formation and maintenance of the primary BCR repertoire, I
reasoned that Presenilins might also play a role in BCR repertoire selection.
Consistent with this possibility, mature splenic B cells (CD19+ AA4-) revealed a
dramatic decrease in the percentage of λ+ B cells (Fig. 24A). The ratio of mature
B cells bearing κ versus λ light chains was raised from 19.61+/- (.35) in controls
to 50.32 +/- (4.9) in PS DKO B cells (Table 4). The decrease in λ+ B cells was
also detected in the splenic transitional B cell pool (CD19+ AA4+) from PS1/PS2
DKO mice, suggesting that the generation of λ+ B cells is defective in the
absence of Presenilin proteins. Similar observations were evident with the loss
of a single isoform of Presenilin 1 or Presenilin 2 (Fig. 24A & Table 4). Further,
examination of the BM, spleen and peritoneal cavity B cell pools demonstrated
decreased frequencies of λ+ B cells across all tissues in the absence of
Presenilins (Fig. 25). In contrast, frequencies of λ+ B cells in CD19+/Cre
Rosa26+/DNMAML-GFP mice did not differ from the CD19+/Cre controls across all B
cell subsets (Fig. 25). These data indicate that Presenilins play a fundamental
role in shaping BCR repertoire without engaging the Notch pathway.
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Figure 24. Generation of λ-chain positive B cells with and without Presenilins.
(A) Splenocytes from 12-week old mice of the indicated genotypes were stained with
the indicated antibodies before collection of 300,000 events on an LSR2 flow
cytometer. The left-most panels are gated on DAPI cells, and the indicated parent
+
gates were used to examine frequencies of l cells in transitional and mature B cells.
Flow plots representative of at least three animals per group.. All data representative
of three separate experiments.
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Figure 25. Decrease in λ-chain positive cells is Notch independent and occurs within
the immature bone marrow B cell compartment. Representative flow cytometric data of
+
high
+
+
BM immature (CD19 IgM
AA4 , left column), mature splenic (CD19 AA4 , center
+
+
column), and peritoneal cavity B1 (CD19 CD43 , right column) B cells from the indicated
mice. All plots also gated on viable (DAPI ) cells. For (A) and (B) numbers within plots
represent the frequency of events as a function of the indicated parent gate
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Table 4. Altered kappa/lambda ratios in Presenilin-deficient mice
B Cell Subset

Genotype

%λ

%κ

Ratio κ/λ

Immature

CD19+/Cre PS1+/+ PS2+/+

8.12

85.80

10.62

(.37)

(.85)

(.60)

4.40

80.13

20.66

(.96)

(7.68)

(5.64)

6.28

70.76

15.59

(2.48)

(7.02)

(5.75)

2.79

78.58

28.97

(.26)

(4.76)

(2.65)

4.75

93.13

19.61

(.07)

(.20)

(.35)

1.39

88.43

70.37

(.35)

(6.17)

(13.58)

.95

79.73

85.47

(.13)

(6.21)

(7.27)

1.71

84.08

50.32

(.14)

(5.10)

(4.9)

CD19+/Cre PS1f/f PS2 +/+

CD19+/+ PS1+/+ PS2-/-

CD19+/Cre PS1f/f PS2-/-

Mature

CD19+/Cre PS1+/+ PS2+/+

CD19+/Cre PS1f/f PS2 +/+

CD19+/+ PS1+/+ PS2-/-

CD19+/Cre PS1f/f PS2-/-

+

+

+

-

Immature B cells (CD19 AA4 ) and mature B cells (CD19 AA4 ) were gated as shown in Figure
20A. Percentages are means foe 3-5 animals per group, SEMs are indicated within parentheses.
+
+
Ratio calculated by dividing the frequency of κ cells by the frequency of λ cells for each B cell
subset.
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4.3 Chapter 4 Summary-Brief Discussion
In this chapter I demonstrate that FOL B cells co-cultured with GSI exhibit
decreased proliferative responses to BCR cross-linking, furthermore I show that
GSI is not overtly toxic to B cells.

Previous studies documented a similar

phenotype in T-cells stimulated through the T cell receptor (TCR) in the presence
of GSI, leading to the interpretation that the Notch pathway was critical to TCR
mediated proliferation (Palaga, Miele et al. 2003). Given that the γ-secretase
complex can catalyze the cleavage of multiple single pass transmembrane
proteins I sought to examine the involvement of the Notch pathway in GSI treated
B cell cultures. To this end I employed an inducible DNMAML construct, and
demonstrate that canonical Notch signaling is dispensable for normal BCR driven
proliferation. This observation does not contradict previous work from our lab
highlighting a role for the Notch pathway in enhancing BCR driven responses, as
the data presented herein only rule out a requirement for the Notch pathway in B
cell activation.
To extend our observations beyond inhibitor based studies I choose to
utilize a loss of function approach in which the catalytic components of the γsecretase complex (Presenilins) were conditionally deleted from the B-lineage.
Using FOL B cells from PS1 PS2 deficient mice I demonstrated a cell intrinsic
defect in BCR responsiveness, especially at suboptimal doses of anti-IgM crosslinking antibody.

These data demonstrate a role for Presenilin proteins in

modulating BCR activation and agree with and extend the recent findings of Yagi
et al. In contrast to observations made by Yagi et al. I do not find that B cells
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lacking Presenilin proteins exhibit defective proliferative responses to LPS
stimulation (Yagi, Giallourakis et al. 2008).

A potential explanation for this

inconsistency is that their data did not control for differences in splenic B cell
subset composition in Presenilin-deficient and wild type control animals. Indeed,
it is well established that MZ B cells are highly enriched for LPS-responsive cells
(Oliver, Martin et al. 1997), and this population is absent from PS1/PS2 DKO B
cell pools, presumable due to failed Notch2 activation. In contrast all experiments
assessing B cell activation herein employed positively selected CD23+ B cells,
which are highly enriched for FOL B cells and lack MZ B cells. Therefore I posit
that the previous data suggesting that LPS responsiveness in B cells requires
Presenilins instead reflect differences in B cell subset composition among
Presenilin-deficient and control splenocytes.
Given the suboptimal BCR responsiveness of Presenilin deficient B cells I
next examined calcium mobilization downstream of the antigen receptor. My
data suggests that the magnitude of the initial release of ER calcium stores is
dampened in the absence of Presenilin proteins. This observation is consistent
with the notion that Presenilins modulate BCR signaling. My observation that the
B1 B cell compartment is dramatically reduced in Presenilin deficient mice also
supports this hypothesis, as B1’s are thought to require stronger signaling
through the BCR for their generation (Casola, Otipoby et al. 2004).

An

alternative explanation for the dearth of B1 B cells in these mice is that the
maintenance and not the generation per se of the B1 B cell pool is perturbed,
such that the self-renewing capacity of the B1 pool is compromised.
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Finally, I observed that while FOL B cells develop in the absence of
Presenilins, the BCR repertoire of this pool as indicated by the decreased
frequency of λ+ cells, is altered.

Furthermore, this decrease in λ+ cells is

observed within the immature B cell populations of the spleen and bone marrow
suggesting that the generation and not the maintenance of λ+ bearing cells is
defective in PS1/2 deficient cells.
In conclusion, this chapter provides the first evidence of a role for
Presenilin proteins in the development, activation, calcium signaling and BCR
repertoire formation of B-lymphocytes independent of the canonical Notch
signaling pathway.

Clearly, future studies are required to dissect how the

described phenotypes are dependent or independent of the enzymatic activity of
Presenilin proteins. Given that GSI is currently in clinical trials to treat Notch
driven T-cell leukemia, my work emphasizes the need to further understand
Presenilin and γ-secretase complex function in B cell biology.
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Figure 26. Role of Presenilins in B cell biology. Presenilins are required for normal
B1a, B1b and BCR repertoire development independent of the Notch pathway. In
addition, Presenilins promote BCR mediated proliferation and normal calcium mobilization
in response to antigen receptor cross-linking. Presenilin mediated cleavage of Notch
drives the MZ B cell fate.
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Chapter 5:
5.1

Overall Discussion

Akt1 and Akt2 in bone marrow B cell development
In this thesis, I have shown that Akt1 and Akt2 are dispensable for the

development of pro, pre, and immature B cells (Fig 5). This result was in some
ways surprising given the requirement for Akt1/2 dependent signals in analogous
stages of thymocyte development (Juntilla, Wofford et al. 2007; Mao, Tili et al.
2007). The simplest explanation for my finding is that the remaining Akt3, is
sufficient to promote the early stages of B cell development. Indeed, I find Akt3
mRNA in pro, pre and immature B cell populations (Fig 12), this is in contrast to
thymocytes that express negligible levels of Akt3 mRNA and protein (Juntilla,
Wofford et al. 2007). A drawback of my study is that I did not examine Akt3
protein expression of in these early B cell progenitors. Therefore it remains to be
seen if the Akt3 mRNA is actually translated into protein in these cells. These
data would further support the hypothesis that Akt3 is sufficient to mediate early
B cell development in the absence of Akt1 and Akt2. An alternative explanation
is that early B cell populations develop independently of Akt signaling in general.
This notion is supported by the observation that deletion of molecules upstream
of Akt activation, for example p110δ or CD19, contain intact pro, pre and
immature B cell compartments in steady state animals (Rickert, Rajewsky et al.
1995; Clayton, Bardi et al. 2002; Otero and Rickert 2003). Clearly, an Akt 3
single knockout as well as an Akt1-3 triple knockout will be required to more
clearly define the role of Akt3 in bone marrow B cell generation. Interestingly, a
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B cell specific Akt1-3 deficient mouse has been generated and is currently being
examined (Rickert,R personal communication).
The increased frequency and cell numbers of these early B cell pools is a
peculiar phenotype given Akt’s positive regulation of cellular metabolism, survival
and cell cycle. If anything, I would expect these pools to be diminished with the
loss of two Akt isoforms. A potential explanation for this observation is that while
Akt is dispensable for the survival of early B cells it is important for their
developmental differentiation. In this model, the absence of Akt1 and Akt2 leads
to an inefficient transition from the immature to mature B cell pool by an unknown
mechanism, perhaps activation of transcription factors downstream of Akt
signaling.

For example, recent work demonstrates a role for Akt mediated

degradation of the Forkhead (Foxo) family of transcription factors at the pro and
immature stage of B cell development.

Foxo expression at these stages

increases Rag transcription. First pre-BCR and then mature BCR signaling at
these respective stages activates Akt, causing Foxo degradation and cessation
of Rag transcription (Amin and Schlissel 2008). This predicts that in the absence
of Akt1 and Akt2 Rag down-regulation is inefficient, and by extension the
regulation of other genes critical to B cell development may be abnormal. In turn
this could lead to a slower developmental kinetic for B cells in the immature
stage. This notion is supported by three independent but related observations.
First, BCR signaling at the immature stage of development activates PI-3K and is
important for promoting positive selection (Verkoczy, Duong et al. 2007).
Furthermore, immature B cells treated with PI-3K inhibitors display the capacity
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for “back-differentiation,” i.e. expression of surface markers and genes typically
associated with the pro and pre B cell stages of development (Tze, Schram et al.
2005). Finally, mice deficient in p110δ or CD19 possess immature B cells with
increased levels of Rag mRNA and contain an increased percentage of λ+ cells,
thus PI-3K-Akt signaling may be critical to prohibiting receptor editing in positively
selected B clones (Diamant, Keren et al. 2005; Llorian, Stamataki et al. 2007).
The immature B cell populations in chimeras established with Akt1/2 deficient
progenitors have increased frequencies of λ+ cells, similar to CD19 deficient
animals, suggesting enhanced receptor editing; possibly the result of crippled
BCR positive selection in the absence of Akt1 and Akt2.

If Akt1/2 deficient

immature B cells are not signaling differentiation efficiently then they might be
susceptible to the “back-differentiation” observed by Tze et al. and this may
explain the increased percentage and numbers of cells found in the pro and pre
B cell gates with flow cytometric analysis. This model may also address the
increased representation of Akt1/2 deficient B cells in competitive mixed fetal
liver chimeras (Fig 9B). Assessment of turnover rates in the pro, pre and
immature B cell compartments by Brd-U pulse-chase, will further understanding
of the kinetics at which cells exit these respective pools. My hypothesis is that if
Akt signals promote efficient differentiation, then turnover rates in each
respective compartment will be decreased.

In addition, if Akt regulates Rag

expression, then sorted immature Akt1/2 deficient B cells should express
increased Rag transcripts. If these predictions hold true, one could speculate
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that ectopic expression of an siRNA capable of Foxo knockdown might restore
the bone marrow B cell compartment to normal proportions.
Recent data from Derudder et al. indicate that NF-kB deficiency leads to
increased frequencies of pre-B cells (Kane, Shapiro et al. 1999; Derudder,
Cadera et al. 2009). Given that Akt signaling promotes NF-kB activity in other
contexts (Kane, Shapiro et al. 1999), the increased numbers of pre-B cells
produced by Akt1/2 DKO progenitors may reflect decreased NF-kB activity in
pro- and/or pre-B cells. Thus experiments testing whether enforced NF-kB
activity decreases numbers of pre-B cells and increases numbers of MZ and B1
B cells in the context of Akt deficiency might provide important information
concerning the mechanism of Akt-dependent development and selection within
B-lineage precursors in the marrow.
Finally, an alternative explanation for the increased frequency of λ-bearing
cells within the immature B cell compartment, is that Akt signaling influences the
accessiability of the RAG complex to the light chain loci. In this model the altered
κ/λ ratio is a product independent of selection mediated by the BCR, but instead
reflects defective cytokine or receptor-ligand interactions critical for opening the
κ-locus or repressing the λ-locus.

5.2

Normal B1 and MZ B cell development requires Akt1 and Akt2.
I find that B1a and MZ B cell development is blocked, and B1b

development is diminished in the absence of Akt1 and Akt2 (Fig 6 & 7). These
findings are consistent with previous reports demonstrating a lack of B1 and MZ
95

B cells in mice deficient for CD19 or components of the PI-3K pathway,
suggesting that Akt is a critical downstream target of these molecules.

In

addition, these data demonstrate that Akt3 alone is insufficient to mediate
development of these subsets. This may reflect the decreased expression of
Akt3 in MZ and B1s relative to the FOL pool (Fig 12) such that the required
aggregate Akt signaling does not reach a required threshold. Alternatively, the
results may indicate that Akt1 or Akt2 can regulate downstream pathways that
Akt3 does not in the context of B1 and MZ development.

Furthermore, I

observed an increased frequency of MZ B cells among naïve CD19+ B cells, in
mice engineered to conditionally express a constitutively active form of Akt (MyrAkt) in the mature B-lineage (Fig 15A). Collectively, these data demonstrate the
importance of the Akt pathway in B1a and MZ B cell development, and indicate a
non-redundant role for Akt1 and Akt2 in the peripheral B cell compartment.
Given Akt’s capacity to regulate a diverse number of biochemical
pathways, I questioned what the mechanistic function of Akt is for MZ B cell
development. Studies by Otero et al demonstrated that MZ B cell development
in CD19 deficient animals could be rescued by transgenic expression of the prosurvival molecule Bcl-2 (Otero, Anzelon et al. 2003). The similarities between
CD19 deficient and Akt1/2 deficient B cells to this point were striking, so I
decided to test the hypothesis that survival was the critical downstream effect of
CD19-Akt signaling.

To this end, I transduced Akt1/2 deficient fetal liver

progenitors with Bcl-xL. While ectopic expression of Bcl-xL enhanced frequencies
of recirulcating B cells in the bone marrow, it was not sufficient to rescue MZ B
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cell development in the absence of Akt1 and Akt2 (Fig 13). It is possible that my
retro-viral approach did not produce sufficient levels of Bcl-xL to mediate rescue.
However, I can offer indirect evidence of the constructs efficacy; first it was able
to mediate increases in mature bone marrow B cells (Fig 13A). Second, in-vitro
assays demonstrated that cells expressing Bcl-xL survived radiation induced
apoptosis again suggesting the construct afforded a survival advantage (not
shown). If I accept that the Bcl-xL construct had efficacy, then the discrepancy
between our findings and Otero et al could reflect inherent differences in the
functions of Bcl-2 vs. Bcl-xL. This possibility will need to be addressed in future
experiments. Should enforced expression of Bcl-2 fail to rescue the MZ lineage
in an Akt1/2 deficient background it raises the prospect of CD19 independent
functions for Akt. Given that the BCR can transiently activate Akt this is a likely
possibility (Li, Davis et al. 1999). Crossing B lineage restricted Myr-Akt mice
onto the CD19 deficient background, followed by an assessment of MZ and B1
development should help to elucidate the Akt dependent functions of CD19.
Notch receptor signaling has the potential to activate Akt in T cells and B
cells, and is absolutely required for MZ B cell generation (Tanigaki, Han et al.
2002; Saito, Chiba et al. 2003; Maillard, Weng et al. 2004; Ciofani and ZunigaPflucker 2005; Thomas, Calamito et al. 2007). To determine if Myr-Akt could by
pass the Notch requirement for MZ B cell development I introduced a dominant
negative MAML construct, capable of inhibiting all canononical Notch signaling,
into B lineage restricted Myr-Akt expressing cells. These data show that Myr-Akt,
while sufficient to increase the frequency of MZ B cells in a wild-type background,
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is insufficient to rescue MZ B cell development in the absence of Notch signaling
(Fig 15B). Therefore, Notch in all likelihood activates pathways in addition to Akt
and perhaps these either independently or combined can regulate Notch’s effect
on MZ B cell development. It is worth noting that Moran et al found a genetic link
between the NFκB and the Notch pathway (Moran, Cariappa et al. 2007), and
perhaps future studies could place an NFκB gain of function approach on a
Notch loss of function and examine the effect on MZ B cell biology.
I also examined cell size as a crude measure of metabolic fitness in Akt1/2
deficient FOL and transitional B cell subsets, and found no difference in
comparison to wild-type cells, suggesting that poor metabolism was not
responsible for the block in MZ development.
B1 and MZ B cells pools are positively selected on self-ligand or strong
tonic signals, and Akt may play an important role in this process. Indeed, BCRCD19 activation mediates positive selection events in the periphery (Martin and
Kearney 2000; Diamant, Keren et al. 2005).

Furthermore, mice deficient in

PTEN have increased frequencies of B1 and MZ, and possess FOL B cells that
fail negative selection in tolerance models (Anzelon, Wu et al. 2003; Browne, Del
Nagro et al. 2009).

These observations, coupled with the fact that Akt is

downstream of the BCR (Otero, Omori et al. 2001), suggest that Akt derived
signals are critical to negative and positive selection in the periphery. Indeed, I
observe a change in the peripheral BCR repertoire as indicated by an increased
frequency of λ+ naïve FOL B cells (Fig 11). Furthermore, I find that proliferative
responses to BCR cross-linking on mature B cell in Akt1/2 deficient splenocytes
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are defective (Fig 8), further supporting that the B cell abnormalities observed in
Chapter 3 of this thesis reflect crippled BCR signaling in the absence of Akt1/2.
In mice deficient in the tyrosine phosphatase CD45 (a positive regulator of
BCR signaling), B cells expressing an Ig transgene with specificity for hen egg
lysozyme (HEL) are positively selected in the presence of soluble antigen, in
contrast to wild-type Ig HEL+ B cell which are rendered anergic in this system
(Cyster, Healy et al. 1996).

It would be interesting to breed the Ig HEL+

transgenic BCR onto Akt1/2 deficient soluble and membrane bound HEL
expressing mice and examine the fate of peripheral Ig HEL recognizing clones.

5.3

Akt 1 and Akt2 are critical for the competitive fitness of peripheral B

cell populations.
Decreased FOL B cell numbers, poor survival in-vitro, and a block in B cell
populations that require stronger BCR signals suggested that Akt1/2 deficient
progenitors may be weak competitors in mixed marrow chimeras. Indeed, the
absence of Akt1 and Akt2 resulted in an absolute defect in the ability to generate
MZ or marginal zone precursor (MZP), furthermore a paucity of donor derived
cells were represented within the FOL B cell pool when matched with wild-type
competitors (Fig 9). This data is reminiscent of competitive chimeras in which
mice deficient in Btk or CD19 were matched with wild-type cells (Sprent and
Bruce 1984; Otero, Anzelon et al. 2003). These data show that Akt is critical to
the competitive fitness of peripheral B cell populations, and demonstrates an
inability to efficiently gain access to or utilize resources crucial to survival. I
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noticed that Akt1/2 deficient B cells started loosing representation as early as the
T2 stage of peripheral B cell development. Interestingly, it is at this stage that
BR3 is up-regulated and begins to govern the size of the peripheral B cell pool
(Stadanlick, Kaileh et al. 2008). Given that Blys-BR3 signaling can activate Akt
(Patke, Mecklenbrauker et al. 2006; Otipoby, Sasaki et al. 2008; Woodland, Fox
et al. 2008) I decided to explore the ability of Akt1/2 deficient FOL B cells to
respond to Blys, finding that these cells do infact respond to Blys (Fig 10A). This
observation suggests that Akt3 may be sufficient for Blys mediated survival,
alternatively, the Akt pathway while activated by Blys does not mediate survival
functions downstream of this pathway.

It is interesting to note that BR3

deficiency does not lead to defects in the B1 pool (Lentz, Hayes et al. 1998), but
Akt1/2 deficient chimeras do show B1 abnormalities. Furthermore, enforced
expression of Bcl-xL was previously shown to enhance the MZ compartment in
BR3 deficient mice (Amanna, Dingwall et al. 2003). If a BR3-Akt axis was critical
to the maintenance of MZ B cells my over-expression of Bcl-xL should have
rescued this population. These observations, coupled with in-vitro data, allows
me to make the general conclusion that Akt1 and Akt2 are not the principle
mediators of survival downstream of Blys signaling. Perhaps an assessment of
Akt1/2 deficient B cell’s capacity to generate the BR3 substrate p100, a classical
NFκB target downstream of the BCR, would more thoroughly examine the role of
Akt in BCR-BR3 cross-talk. Given the inability of Akt1/2 deficient progenitors to
compete with wild-type cells, one might expect p100 generation, while not
absent, could be decreased in response to tonic BCR signals. This experiment
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will help elucidate the mechanism by which Akt1/2 deficient B cells fail to
compete and survive when matched with wild-type cells. Collectively, our results
demonstrate that Akt is critical for competitive fitness, but this requirement is
most likely independent of direct BR3 receptor pathway activity.
A final thought on p100 generation in peripheral B cell populations. The
capacity of the MZ B cell population to generate p100 in tonic or BCR crosslinking studies remains unexplored. A central question to the FOL vs MZ B cell
fate decision is the role of BCR signal strength. It is known that MZ B cells are
more dependent on Blys than FOL B cells (Thien, Phan et al. 2004). Whether
this enhanced requirement reflects too much or too little p100 generation is
unknown, but it is interesting to note that p100 is a target of the classical NFκB
pathway.

As such p100 levels are in part dictated by p50.

MZ B cell

development is blocked in the absence of p50 (Moran, Cariappa et al. 2007).
Furthermore, Notch signaling is required for MZ B cell generation and Notch was
recently shown to stabilize p50 levels (Shin, Minter et al. 2006; Moran, Cariappa
et al. 2007). Does this imply that Notch and the BCR communicate to generate a
specified level of p100 such that BR3 can mediate processing and eventual
transcription of Bcl-xL and Pim2? This could be tested by first examining the
capacity of MZ B cells to generate p100 downstream of BCR cross-linking, this
experiment may require use of a Bcl-xL transgenic mouse as MZ B cells undergo
apoptosis in response to BCR oligomerization. If p100 is generated, the extent of
p100 generation should be examined in MZ B cells co-cultured with OP9 stromal
cells expressing the Notch ligand DL1 by both western and qRT-PCR.
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5.4

Notch independent functions of the γ-secretase complex in BCR
mediated proliferation.
Previous observations demonstrated a synergy between Notch-DL1 and

BCR signaling that resulted in enhanced proliferative and isotype switching
responses (Thomas, Calamito et al. 2007). These experiments forced Notch
signaling upon B cells by co-culturing them with OP9- stromal cells engineered to
express the Notch ligand DL1.

Interestingly, DL1 mRNA is expressed

intrinsically on splenic B cells (Hozumi, Negishi et al. 2004). This observation
raised questions regarding the role for B-cell restricted Notch ligand expression
in BCR mediated activation. To inhibit Notch signaling, I cultured FOL B cells in
the presence of GSI or vehicle control. As described in the introduction, GSIs
block the enzymatic activity of γ-secretase, which is required for Notch pathway
activation. These experiments showed that GSI greatly diminished the ability of
FOL B cells to proliferate in response to antigen receptor stimulation (Fig 17).
This effect was specific to the BCR, as stimulation through TLR4 via LPS did not
perturb CFSE dilution. In addition, I also showed that GSI was not inherently
toxic to B cells as various doses of GSI resulted in the same cell viability when
compared to the vehicle control DMSO. Furthermore, both a Bcl-xL transgene
and retrovirus could not rescue proliferation in GSI treated B cells (data not
shown). Collectively these results suggested that the Notch pathway could not
only enhance BCR mediated proliferation as per earlier published studies, but
that Notch was essential to proliferation via the antigen receptor. A second and
distinct hypothesis was that the effect I observed was Notch independent. This
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was not unreasonable, as over 80 different substrates have been identified as
targets of the γ-secretase complex.

To better understand the mechanism

causing decreased proliferation in GSI treated cultures I decided to target the
Notch pathway specifically.

To this end I employed a system in which a

DNMAML construct could be induced upon pulsing with a cell permeate Tat-Cre,
and it’s expression tracked/sorted via GFP. An advantage of this system was
that it allowed B cell development to occur in the presence of normal Notch
signaling, negating any selective bias that could be introduced as a result of
Notch signaling blockade. As demonstrated in Figure 18 inhibition of canonical
Notch signaling did not have an effect on BCR mediated proliferation across
multiple doses of anti-IgM cross-linking antibody, suggesting that Notch signaling
is not required for normal BCR mediated activation. Furthermore, addition of GSI
to DNMAML expressing or non-expressing cells could repress BCR mediated
proliferation (Fig 18).
These data were compelling, but a concern was that even though I could
track DNMAML expression by GFP and this level of expression was sufficient to
block Notch signaling as required for MZ B cell development, it was possible that
the level of DNMAML reached during the 16hr incubation period before sorting
and subsequent three days in culture was insufficient to block Notch signaling.
To address this concern I harvested FOL B cells from CD19Cre ROSA26

+/DNMAML

mice, these FOL B cells develop in the presence of DNMAML and are at steady
state. Cells in this pool have a life span in excess of three months, thus I’m
confident that FOL B cells from these mice express levels of DNMAML sufficient
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to block canonical Notch signaling. Experiments examining proliferation in these
cells resulted in the same conclusion as those experiments utilizing Tat-Cre;
Notch signaling is not required for BCR driven proliferation.
Previous work performed and published from our lab showed that Notch
could enhance BCR signals. My current results do not refute this finding, as
those studies described a function for Notch in the enhancement of proliferation,
i.e. what Notch “can do”. In contrast, the experiments in this thesis examine the
requirement for Notch in BCR driven proliferation and concludes that Notch is
dispensable for BCR mediated activation. Furthermore, my work, for the first
time in B cells, suggests that the γ-secretase complex has Notch independent
functions in B cell activation.
A limitation of my experimental approach was that it hinged upon chemical
inhibitor based studies that could have off target effects.

To address the γ-

secretase specific phenotype I generated mice with conditional deletion of both
isoforms of the catalytic subunit of γ-secretase, Presenilin 1 and Presenilin 2.
Conditional deletion by a B cell specific Cre was required for the PS1 floxed gene
as conventional PS1 or PS1/2 DKO mice are embryonic lethal (Feng, Rampon et
al. 2001). To examine the B cell intrinsic effects of Presenilin deletion on BCR
mediated activation I performed a mixing experiment in which PS1/2 DKO FOL B
cells were co-cultured with congenic wild-type FOL B cells. These experiments
recapitulated the GSI studies demonstrating defective proliferation in response to
BCR cross-linking in the absence of Presenilin proteins and demonstrate that the
defect is indeed B cell intrinsic (Fig 19A/B). During the course of my thesis work
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Yagi et al published that proliferative responses to BCR stimulation were
abnormal in the absence of both PS1 and PS2, but these authors did not show
that the defect was cell intrinsic. Furthermore, they concluded that Presenilin
proteins were required for proliferation in response to LPS stimulation (Yagi,
Giallourakis et al. 2008). While my observations agree with the BCR mediated
proliferation defects, I do not find that Presenilins are required for LPS
responsiveness. I’d like to point out that these workers did not control for
differences in splenic B cell subset composition in Presenilin-deficient and wild
type control animals. Indeed, it is well established that MZ B cells are highly
enriched for LPS-responsive cells (Oliver, Martin et al. 1997), and this population
is absent from PS1/PS2 DKO B cell pools, presumable due to failed Notch2
activation. In contrast all experiments assessing B cell activation herein
employed positively selected CD23+ B cells, which are highly enriched for FOL B
cells and lack MZ B cells. Therefore, previous data suggesting that LPS
responsiveness in B cells requires Presenilins instead reflect differences in B cell
subset composition among Presenilin-deficient and control splenocytes.
The BCR specific defects suggested that downstream signaling could be
altered. A large body of evidence in neurons implicated Presenilin proteins in
calcium regulation (Cai, Lin et al. 2006; Tu, Nelson et al. 2006; Cheung,
Shineman et al. 2008). To gain a qualitative measure of signaling downstream of
the BCR in the absence of Presenilins I examined calcium mobilization (Fig 21).
These experiments collectively demonstrated that BCR signaling responses are
decreased both in terms of magnitude and kinetics in the absence of Presenilin
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proteins. Experiments performed in calcium free media suggest that the defect
localizes to the initial BCR signaling cascade, implying that BCR activation is
suboptimal. These defects are in agreement with observations made by Yagi et
al showing that Syk phosphorylation is decreased immediately after BCR crosslinking (Yagi, Giallourakis et al. 2008). Presenilin proteins do have functions
independent of their catalytic activity, therefore future experiments utilizing a
catalytically dead Presenilin mutant must be performed to ascertain the
requirement for enzymatic activity in normal calcium mobilization.
Previous studies, some using GSI, concluded that Notch was a critical
factor in the Th1 vs Th2 decision (Minter, Turley et al. 2005; Tu, Fang et al. 2005;
Fang, Yashiro-Ohtani et al. 2007).

My results justify reexamination of this

conclusion, as Minter et al may have been observing a Notch independent
function of the inhibition of the γ-secretase complex. My results demonstrate that
further understanding of the γ-secretase complex is warranted as off target
effects may be more severe than anticipated.

5.5

Requirement for Presenilin in B1a B cell development and BCR

repertoire formation
Mutations or deletion of proteins that strengthen BCR signaling, such as
Btk, often coincide with defective calcium mobilization and a block B1 B cell
development (Khan, Alt et al. 1995; Takata and Kurosaki 1996). Therefore, I
evaluated the peripheral B compartment of PS1/2 deficient mice and discovered
a severe block in the generation of B1a B cells and overall decrease in the B1
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compartment (Fig 23A). Furthermore, loss of a single isoform of PS1 or PS2
resulted in a similar albeit less dramatic decrease in the B1 pool. I also noted
that CD19+/Cre Rosa26

+/DNMAML

mice do not show a defect in B1 B cell

development (Fig 23B), again demonstrating that the effect is Notch
independent. These data, combined with the proliferation and calcium defects
characterized above, imply that Presenilins function to optimize BCR signaling
and potentially promote the selection of B1a and to a lesser extent B1b B cells.
An alternative explanation is that B1 B cell generation is normal in the
absence of Presenilin proteins, but that the maintenance of this subset is
defective, perhaps through defective self-renewal.

Future experiments will

examine the B1 compartment in young mice to determine if B1 B cells are
present at this early stage. This is a critical experiment in that my current data
only supports the hypothesis that abnormal BCR signaling is responsible for
generating B1a cells, the possibility remains that altered self-renewal is the
defect.
Additional support for a Presenilin dependent function in BCR signaling
and B cell development came from examination of the BCR repertoire as
measured by λ frequencies. As shown in Figure 24 of PS1 and PS2 resulted in
decreased frequencies of λ bearing cells.

Furthermore, this effect was also

observed in single knockouts. As λ frequencies are thought to be representative
of the extent of receptor editing (Nemazee 2006), these data suggest that
receptor editing is diminished in the absence of Presenilin. This may represent
altered negative/positive selection as a result of abnormal BCR signaling.
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Strikingly, studies from Laky et al showed that positive selection of
developing T cells is compromised in PS1/PS2-deficient thymocytes, and led to
models proposing that Notch activity regulates TCR signal strength during
thymocyte development (Izon, Punt et al. 2001; Laky and Fowlkes 2007).
However, in combining these observations with my data, it suggests that many of
these effects may instead reflect Notch-independent functions for Presenilins.
Therefore, whereas my results do not minimize the importance of Notch signaling
in T and B cell development and function, they emphasize the need to
understand the additional roles played by Presenilins in the immune system.
5.6 Concluding remarks
My work shows that Akt1, Akt2 and Presenilins are critical factors in the
generation of positively selected subsets, the peripheral BCR repertoire and BCR
driven proliferation (Fig 27). My data combined with observations from other
labs suggests that these molecules are critical targets of BCR signaling, and may
serve to strengthen antigen receptor signals.

An unanswered but important

question is how CD19 and the BCR converge on Akt to drive the B1 and MZ fate.
The data presented in this thesis suggests that survival and metabolism are not
solely responsible for the block in the generation of these subsets. For Presenilin
a clear question that needs to be addressed is whether the defects observed in B
cell development depend upon the catalytic activity of the γ-secretase complex,
and if so what is the substrate (Fig 27)? It would also be advantageous to
generate mice deficient in Akt or Presenilins harboring Ig heavy chains such as
M167 or 81x with idiotypes that drive defined cell fates within the B-lineage,
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studies such as these will more precisely determine the role of these molecules
in negative and positive selection.
Some twenty years ago Herzenberg and colleagues proposed the idea of
a “layered immune system” in which the evolutionary most primitive cellular
subsets would arise first. From this foundation additional layers could be built
increasing in complexity and providing survival and reproductive advantage to
the organism (Herzenberg 1989). In relation to B cell biology, B1 and MZ B cells
with their “innate-like” T- cell independent functions may serve as the foundation
of the humoral immune response. From this foundation, the more complex Tdependent, germinal center reactions dominated by FOL B cells evolved. The
biochemical pathways utilized by this evolutionary process are poorly
understood. Examination of previously published data and the work presented
within this thesis demonstrates that though B1 and MZ cells may function in a
more primitive way, the developmental requirements of these cells may be more
complex than that of FOL B cells. This implies that evolution favored “relaxing”
positive selection standards to increase the diversity of antigens recognized and
enlarge the overall B cell repertoire.
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Figure 27. Akt and presenilin promote BCR signaling and support generation of innatelike B cell populations. B cells deficient in Akt1/2 are phenotypically very similar to CD19 or
PI-3K loss of function cells. These observations suggest that Akt is a required downstream
target of these molecules in the generation of the normal peripheral B cell pool. Presenilins
while required to generate MZ in a Notch dependent manner, also play critical Notch
independent functions downstream of the BCR in the development of B1 B cells and BCR
repertoire formation. Collectively, Akt1/2 and Presenilins are important molecules in the
generation and propagation of signals derived from the BCR and thus play a critical role in the
formation of the humoral arm of the immune system.
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Appendix A.

Appendix Figure 1: Early B cell development is normal in the absence of Akt1 or
Akt2. (A) Representative flow cytometric analysis of BM cells from wild-type (top)
+/+
-/Akt1 (middle) Akt2 (bottom). The left-most plots are gated on viable donor-derived
(DAPI ) cells. Numbers in plots indicate the frequency of events in the indicated gate as
+
+
+
+
a function of the indicated parent population. Pro-B, CD43 B220 CD19 AA4 ; pre-B,
low
+
+
+
+
+
CD43 B220 IgM AA4 ; immature B, CD43 B220 IgM AA4 ; mature B, CD43
+
+
B220 IgM AA4 .
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Appendix Figure 2: MZ B cell development is intact with loss of a single isoform
-/of Akt1 or Akt2. Representative analysis of splenocytes from wild-type (top), Akt1
-/(middle), or Akt2 (bottom) mice. Viable donor-derived cells were gated as in Figure 1.
Numbers in plots show the frequency of events as a function of the indicated parent
gate.
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